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ABSTRACT
PURPOSE: The purpose of this thesis was to characterize quadriceps
neuromuscular dysfunction in patients with knee osteoarthritis (OA). Concerns
pertaining to study design in this patient population (e.g. disease severity criteria
and muscle imaging outcome measures) were also addressed.
METHODS: Five studies were undertaken using data acquired from volunteers
recruited at the local institution and from participants in the public source dataset
of the Osteoarthritis Initiative (http://oai.epi‐ucsf.org/datarelease/). Clinical
disease severity was evaluated with the Western Ontario and McMaster
Osteoarthritis Index (WOMAC). Radiographic severity was evaluated with Kellgren‐
Lawrence Grading (KLG). Quadriceps muscle isometric strength and isotonic power
were measured with dynamometry. Voluntary activation (VA) of the quadriceps was
determined with the interpolated twitch technique. Information about intrinsic
properties of the neuromuscular system were assessed with magnetic resonance
imaging (MRI) derived measures of muscle volume, intramuscular and surface
electromyography and measurement of evoked contractile properties.
RESULTS: Radiographic definition of disease severity displayed a ceiling effect and
led to underestimation of quadriceps muscle weakness in patients with knee OA
(Chapter 2). Quadriceps muscle isometric strength, velocity and isotonic power
were reduced across a clinical spectrum of knee OA, however muscle quality (i.e.
specific torque and specific power were unaffected, Chapter 3). Quadriceps whole
muscle volume, measured with MRI can be reliably measured and was strongly
associated with isometric strength (Chapter 4). VA deficits were minimal in knee OA
iii

patients, even in those with severe knee pain and disability (Chapter 5). No changes
in evoked contractile properties were observed across a clinical spectrum of knee
OA, however average motor unit size was larger and firing rates slightly lower in
patients with knee OA compared to healthy controls during submaximal
contractions (Chapter 6).
CONCLUSION: This thesis provided information about the magnitude and
mechanisms of quadriceps neuromuscular dysfunction in patients with knee OA,
which have consequences with regard to the treatment and prognosis of this
disorder. Furthermore, the information provided about the validity of commonly
used predictor variables and outcome measures has implications for future study
design in this disease population.

KEYWORDS: knee osteoarthritis, quadriceps strength, quadriceps power,
interpolated twitch technique, magnetic resonance imaging, Kellgren‐Lawrence
grading, motor unit
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CHAPTER 1
QUADRICEPS MUSCLE WEAKNESS IN KNEE OSTEOARTHRITIS

1.0 GENERAL INTRODUCTION
1.0.1 Knee Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis, affecting over 10%
of adults in Canada.1 The prevalence of OA increases with age and the burden on
health care systems will increase exponentially as older adults continue to comprise
a larger proportion of the population. By age 65, up to 80% of people have
radiographic features of OA in at least one joint.45 The knee is a frequently affected
joint in the lower limb with up to 65% of people over age 65 years of age
demonstrating radiographic evidence of knee OA.6
The characteristic structural features of knee OA are articular hyaline
cartilage degradation (seen as non‐uniform joint space narrowing on X‐ray),
osteophytosis, bony sclerosis and subchondral cyst formation (Figure 1.1). The
knee is a tri‐compartmental joint (patellofemoral, medial tibiofemoral and lateral
tibiofemoral compartments) and OA can be isolated or multi‐compartmental. The
hallmark symptoms of knee OA are pain on most days, morning stiffness (usually
lasting less than 30 minutes), the absence of systemic features and instability
leading to a reduction in the capacity to perform activities of daily living (ADLs).
Data from the Framingham study reveal that disability caused by knee OA equals
heart disease and is greater than other common diseases of aging such as diabetes

Figure 1.1 Osteoarthritis of the medial side of the knee (From Felson DT. Clinical
Practice. Osteoarthritis of the knee. N Engl J Med 2006; 354(8): p 841‐8).22 Used
with permission from the Massachusetts Medical Society.
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and chronic obstructive pulmonary disorder.31 Consequently, an understanding of
the etiology, pathophysiology and natural history of knee OA is paramount.
Traditionally, knee OA has been defined as a disease of articular cartilage and
accordingly, a large proportion of the literature is devoted to understanding the
molecular mechanisms of cartilage degradation in order to develop treatments
aimed at preventing cartilage loss (i.e. chondroprotection). However,
chondroprotection strategies have proven unsuccessful thus far and may not
adequately address the symptom of knee pain as cartilage itself is aneural.23 A more
recent approach asserts that knee OA constitutes “whole organ failure” as all joint
structures including cartilage, bone, ligaments, synovium, menisci and muscle are
affected.37 In particular quadriceps muscle weakness is associated with pain and
loss of function and has been suggested as a risk factor for disease incidence and
progression.21 Quadriceps muscle strengthening has long been an accepted part of
the continuum of strategies designed to reduce symptoms of knee OA (Figure 1.2).71,
72

However, the effect sizes of knee extensor strengthening on quality of life

outcome measures are small25 and some clinical trials using quadriceps exercise as
an intervention have not shown positive results.5 Also, a single clinical trial failed to
report any benefit for quadriceps strengthening on structural knee OA progression53
and there is evidence that decreased quadriceps strength is even a risk factor for
disease progression in malaligned and lax knee joints.64 An incomplete
understanding of the magnitude, mechanisms and natural history of quadriceps
weakness, leading to inappropriate and poorly timed interventions could be
1.0.2 Quadriceps Muscle Weakness in Aging and Knee Osteoarthritis
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Figure 1.2 Stepwise algorithm for the management of patients with osteoarthritis.
This is an example of a treatment algorithm that is modified according to a patient's
response and clinician's preference. It highlights the encompassing need to consider
non‐pharmacological management as first line for all patients (From Hunter DJ and
Felson DT. Clinical Practice. Osteoarthritis. BMJ 2006; 332(7542): p 639‐42).37 Used
with permission from BMJ Publishing Group Ltd.
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Both OA and normal biological aging are associated with a decline in skeletal
muscle function and mobility that can be attributed in part to a loss of muscle
strength. It has been reported that such deficits are magnified in older subjects with
chronic knee pain or radiographic evidence of knee OA. For healthy older subjects
between 60‐80 years, knee extensor strength appears to be 20‐40% lower than
healthy young subjects for isometric, isokinetic and isotonic contractions.19, 69, 70 It
is important to note that quadriceps weakness in knee OA is not simply a result of
aging as knee extensor strength is reduced an additional 20‐40% for isometric 33, 38,
40, 47, 48

and isokinetic 24, 32, 35, 65 contractions, compared to healthy older subjects.
In healthy older adults, cross‐sectional and longitudinal observations have

shown that strength loss begins in the 6th decade but its progression is highly
variable depending on the individual and muscle group studied.43 With respect to
studies of the knee extensors, Frontera et al. showed decrements in isokinetic knee
extensor strength of 23% for slower velocities (60°/s) and 30% for higher velocities
(240°/s), along with a significant decrease in muscle cross‐sectional area (CSA),
during a 12‐year follow‐up of male subjects from a previous study.26 Interestingly,
cross‐sectional data from this group estimated the rate of strength loss to be 1.5
N·m‐1·yr‐1, compared to 3.2 N·m‐1·yr‐1 in the follow‐up study, suggesting that cross‐
sectional studies underestimate the rate of strength decline in this population.27
Similarly, Aniansson and colleagues found a reduction in isokinetic knee extensor
strength (30°/s) of 18% for males and 13% for females between 70 and 75 years.4
Hughes et al. found a decline of 14%/decade between 46 and 78 years, with the rate
of strength loss higher in the older subjects of the study group, while testing for

5

isokinetic strength at a velocity of 60°/s.36 Information about the rate and
magnitude of decline in knee OA is limited to a single study. Messier et al.
documented changes in physical function and balance over a 30‐month period in
480 subjects aged 65‐85 years with chronic knee pain and knee OA.52 The results
showed significant decrements in lower‐extremity isokinetic strength (concentric
knee extension declined by 12.1%). It should be noted that subjects in the upper
quartile of strength at baseline experienced the lowest rate of decline, whereas
those in the lowest baseline strength quartile experienced the highest, suggesting a
protective effect for lower‐extremity muscle strength in OA. This longitudinal study
provides evidence of progressive muscle dysfunction in knee OA, however it is not
conclusive for a more rapid rate of decline compared to a healthy cohort. Taken
altogether, the results of the aforementioned studies indicate that the rate of
isokinetic knee extensor strength decline in healthy subjects is between 1.5‐
3%/year, in comparison to the study by Messier et al. (in OA subjects) reporting a
decrement in isokinetic strength of 4.8%/year. This tangential comparison is of
limited utility in that it doesn’t consider differences in age, sex and methodology, but
it does highlight the need for further research into the possibility that the rate of
strength decline is more rapid in knee OA. The consequences of reduced quadriceps
strength are twofold; 1) the quadriceps may act to protect the knee joint from
harmful loading forces, thereby preventing disease incidence and progression; and
2) quadriceps muscle impairment leads to disability.
1.0.3 Quadriceps Muscle Weakness as a Risk Factor For Incident and
Progressive Knee Osteoarthritis
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Risk factors for development and progression of knee OA are divided broadly
into systemic versus local.21 There is evidence to suggest the breakdown of
neuromuscular protective mechanisms around the knee joint (e.g. quadriceps
muscle weakness) is a local and modifiable risk factor that increases the risk for
knee OA. In two cross‐sectional studies, quadriceps weakness was significantly
correlated with radiographic knee OA even in those who did not describe symptoms
of knee pain.6, 65 In a longitudinal prospective cohort study, Slemenda et al. followed
healthy women for a mean of 31.3 months and reported that quadriceps muscle
strength in women who developed radiographic knee OA was 18% lower than those
who did not.66 Further evidence comes from Becker et al. who reported reduced
quadriceps strength in a group of patients who had undergone medial
meniscectomy (presumably a “preosteoarthritic” state), compared to healthy
controls.10
Biomechanical analysis of gait may provide a plausible mechanism to explain
how quadriceps muscle weakness causes incident and progressive disease.
Eccentric contraction of the quadriceps muscle prior to and during heel strike
provides deceleration of the lower limb and shock absorption from the loading
impulses generated at heel‐strike during the gait cycle.16 A few studies report
increases in loading forces in models of weak quadriceps, but these findings have
not been extended to models of knee OA.42, 58 A more likely scenario involves a
complex interplay of neural gait strategy, knee joint alignment and quadriceps
function causing abnormal loading forces on a susceptible knee joint.60, 62 In animal
models, quadriceps weakness induced by botulinum injection actually caused
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reduced loading forces across the knee joint, but led to degenerative changes in
patellofemoral cartilage.50, 59 Despite conflicting evidence as to the exact
mechanism, altered quadriceps muscle function is implicated in disease initiation.
Studies of disease progression and quadriceps function are more limited and
less consistent than studies of disease incidence. One longitudinal study reported
no protective effect for quadriceps muscle strength on structural disease
progression.15 Furthermore, a clinical trial for quadriceps strength training
reported no benefit on structural OA outcome measures.53 It could be that the effect
of quadriceps strength is dependent on the stability and alignment of the knee joint
affected,64 although more experimental evidence is needed to substantiate this
theory.
1.0.4 Mechanisms of Quadriceps Muscle Weakness in Knee Osteoarthritis
The traditional model of muscle weakness in knee OA is one whereby chronic
disuse due to knee pain precipitates muscle atrophy, resulting in further disuse.
There are a few studies providing direct evidence that muscle atrophy (presumably
from disuse) is a primary mechanism of quadriceps muscle weakness. Ikeda et al.
reported a 12% reduction in quadriceps muscle mass in women who displayed
evidence of incident radiographic knee OA compared to those who did not.41
Subsequently, Peterson et al. reported that patients with end‐stage (KLG = IV)
radiographic knee OA displayed a 12% reduction in muscle cross‐sectional area
compared to a healthy contralateral leg.57 It is possible that quadriceps muscle
weakness in knee OA represents a process of “accelerated aging” whereby the
mechanisms of sarcopenia (e.g. muscle fibre loss, increased proportion of the type I
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muscle fibres and selective type II fibre atrophy) are occurring at a faster rate.19 In
support of this theory, a recent study by Ling et al. assessed motor unit (MU)
properties during voluntary contractions in patients with radiographic knee OA.48
During low‐intensity contractions, the mean amplitude of the surface motor unit
action potential (S‐MUP) sampled with needle electromyography was higher for
knee OA patients than for controls. This finding is consistent with the MU
denervation‐collateral reinnervation process documented in healthy aging, which
accounts for larger MUs being recruited at low‐intensity contractions.68 Further
study of muscle contractile and MU properties as well as analysis of individual
muscle fibre properties is required to determine if atrophy is occurring and identify
potential mechanisms.
Beyond disuse atrophy, there is ample evidence supporting impairment in
neuromuscular function as a cause of reduced strength. Numerous studies report a
reduction in the ability of the central nervous system to recruit and maximally rate
code all available MUs during maximal voluntary contraction (i.e. voluntary
activation (VA) deficits).10, 14, 33, 38, 40, 57, 67 Afferent excitation from pain, effusion or
joint damage, may lead to increased alpha‐motor neuron inhibition during voluntary
contractions, a mechanism termed “arthrogenous muscle inhibition”.38 Other
studies have shown no difference in VA between knee OA and healthy subjects, in
particular in younger subjects with less severe disease.34, 47 It is possible that
disease severity determines the ability to maximally activate the quadriceps,
although this has yet to be examined.
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Another proposed neuromuscular mechanism for reduced strength is an
increase in co‐contraction of the antagonist muscles, perhaps in an attempt to
stabilize an abnormal knee joint.46 At this point, only one study has investigated co‐
contraction as a mechanism for reduced quadriceps muscle strength in knee OA
with no changes in co‐contraction reported.34 Until the mechanisms of muscle
weakness in knee OA are accurately characterized, the design of mechanism‐
appropriate rehabilitation strategies is challenging.
1.0.5 Relationship with disability
Research highlighting the causes of disability and pain in knee OA is essential
to the process of developing rehabilitation programs to combat the burden of
disease. It has been documented that the severity of radiographic change alone is a
poor predictor of clinical symptoms of OA,18, 51, 54, 56 but a large proportion of
research is still aimed at establishing causation between risk factors and
radiographic onset and progression. Lower extremity muscle strength is a critical
predictor of functional performance and dynamic stability during ADLs, and
disability is common as strength declines with age. Although less attention has been
devoted to these principles by OA researchers, available data suggest that the
reduction in quadriceps muscle strength creates a significant disability burden in
this population. Two large studies of community dwelling subjects reported that
muscle weakness is a stronger predictor of disability and pain than structural
radiographic OA. McAlindon et al. assessed disability with the Stanford Health
Assessment Questionnaire44 in 155 subjects and found a significant protective
association with isometric quadriceps strength (OR=0.84).51 There was no
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association between Kellgren‐Lawrence grade (KLG) and disability. O’Reilly et al,
measured similar variables in 300 subjects and found that muscle strength was a
significantly stronger predictor of knee pain than radiographic score.55 In addition,
the authors analyzed a subgroup of those with knee pain independently and found
that muscle strength, but not radiographic score was strongly predictive of disability
in this subgroup. Both of these studies stratified strength into quartiles, with those
in the lowest quartile experiencing a threefold or more increase in disability and
pain.
The results of large prospective population studies confirm cross‐sectional
data and also establish the temporality of the relationship, with muscle weakness
preceding disability. In the Women’s Health and Aging Study II, Ling et al. found
that knee extensor strength was an independent predictor of the transition from
normal function to both mobility and ADL limitations over 72 months, in women
aged 70‐79 with knee OA.49 Furthermore, longitudinal studies have shown that
lower knee extensor strength increases the risk of poor function in previously
disabled adults with OA. Messier et al, found that the greatest declines in isokinetic
strength over thirty months in those aged 65 years and older with chronic knee pain
were associated with the worst balance scores (measured as the excursion of the
centre of pressure in the anterioposterior plane on a force platform).52 Over three
years, Sharma et al. found that performance during a chair‐stand test was strongly
influenced by maximal isometric quadriceps strength and proprioception, in those
with radiographic knee OA at baseline.63 However, the relationship between
strength and performance was lost after adjustment for knee pain and scores on a
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self‐efficacy scale, highlighting the close relationship between muscle strength, pain
and psychological factors.
Thus it is evident that in order to reduce the disability burden in those with
knee OA, quadriceps muscle weakness must be attenuated. It is the objective of this
thesis to characterize the magnitude, natural history and mechanisms of quadriceps
muscle dysfunction in knee OA. A comprehensive understanding of quadriceps
muscle function in this disease population will provide a scientific basis for the
interventions and outcomes used in clinical trials designed to attenuate weakness,
disability and perhaps the disease process itself.
1.1 OVERVIEW OF THESIS CHAPTERS
The objectives of this thesis are 1) to determine how variability in study
methodology influences the measurement of quadriceps muscle parameters in knee
osteoarthritis (OA) and 2) to gain insight into the natural history and mechanisms of
quadriceps muscle dysfunction across a clinical spectrum of knee OA. To address
the first objective, data obtained from patients recruited locally was analyzed in
conjunction with data obtained from the public use datasets of the Osteoarthritis
Initiative (OAI, version 0.2.2 clinical dataset, version 0.E.1 imaging dataset; online at
www.oai.ucsf.edu). The influence of disease severity definition (i.e. radiographic vs.
clinical) on isometric quadriceps muscle weakness was assessed (experiment 1),
along with the effect of muscle size definitions, clinical disease severity and
segmentation procedures on the quadriceps muscle size‐strength relationship
(experiment 3). To address the second objective, locally recruited volunteers
stratified into clinically defined mild, moderate and severe knee OA subgroups,
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underwent comprehensive neuromuscular evaluation. Quadriceps muscle strength
and power (experiment 2), muscle volume and voluntary activation (VA, experiment
4) and muscle contractile and motor unit (MU) properties (experiment 5) were
assessed across a clinical spectrum of disease, to gain further insight into the natural
history and mechanisms of neuromuscular dysfunction in knee OA.

1.1.1 Experiment 1
Objectives: To determine 1) the influence of disease severity definition (i.e. clinical
versus radiographic) on outcome measurement in knee OA research, 2) the natural
history and magnitude of quadriceps muscle weakness in patients with knee OA and
3) the relationship between two commonly used measurement tools in knee OA
research; The Western Ontario and McMaster Osteoarthritis Index (WOMAC)12 and
Kellgren‐Lawrence Grading (KLG) for radiographic knee OA.
Rationale: Assessment of the relationship between clinical and radiographic knee
OA is necessary because 1) the definition of disease severity status using a
composite index of pain, structural and functional features has been identified as a
means of developing valid outcome measures for clinical trials,30 2) stratification of
patients in descriptive and randomized studies is commonly performed using
radiographic criteria in isolation or combined with clinical criteria61 and 3) X‐rays
are perceived to be helpful in making management decisions by clinicians.11 Any
discrepancy between clinical and radiographic features has potential negative
consequences, including heterogeneity in the severity of study groups (e.g. severe
clinical but mild radiographic disease) and a confounding influence on OA
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management. WOMAC and KLG are routinely used in knee OA research (both as
predictor variables and outcome measures) and the nature of their relationship
remains unclear.7, 17, 20

1.1.2. Experiment 2
Objective: To determine whether deficits in quadriceps isotonic power exist across
a clinical spectrum of knee OA and whether these deficits predict loss of function.
Rationale: Many studies have documented deficits in isometric and isokinetic knee
extensor strength in patients with knee OA compared to healthy controls and/or a
healthy contralateral limb.13 No study to date has investigated whether a similar
deficit in muscle power (the product of torque and velocity) exists or whether the
torque‐velocity relationship is affected. Reports from the literature on aging suggest
that power deficits are more robust than isometric strength measures in predicting
reduced ability to perform the activities of daily living.8, 9

1.1.3. Experiment 3
Objective: To describe the quadriceps muscle size‐strength relationship in patients
with knee OA and to determine the influence of variation in 1) muscle size measures
derived from magnetic resonance imaging (MRI; e.g. whole muscle volume vs. single
slice anatomical cross‐sectional area; ACSA), 2) disease severity and 3) MRI
protocol, on this relationship.
Rationale: Despite the evidence that the number and size of muscle fibres is a
primary determinant of strength,29 between‐study variation in the size‐strength
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relationship has been reported, with some studies observing weak‐to‐moderate
correlations2, 70 and others observing stronger relationships.28 In particular, one
study of patients with severe structural knee OA observed that mid‐thigh
quadriceps ACSA predicted only 27% of the variance in isometric quadriceps
strength.57 It has been suggested that variation in the size‐strength relationship is
due to differences in the definition of muscle size.3

1.1.4. Experiment 4
Objective: To determine the mechanisms underlying quadriceps muscle weakness
in knee OA.
Rationale: It is commonly proposed that quadriceps weakness in knee OA is due to
atrophy from pain, disuse or both.13 Few studies however, have attempted to
document and quantify the extent of muscle atrophy. Furthermore, there is
evidence from some studies, that deficits in VA (presumably from joint pain causing
afferent inhibition of motor neurons) are responsible for strength deficits,14, 33, 38, 39
though not all studies have observed this phenomenon.47 Additionally, no study to
date has investigated whether the mechanisms of muscle weakness are altered
throughout the natural history of disease.

1.1.5. Experiment 5
Objective: To determine whether evoked quadriceps muscle contractile properties
and MU properties are altered in knee OA.
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Rationale: It was observed that quadriceps muscle strength is strongly associated
with quadriceps muscle volume (experiment 3) and that volume is less in those with
severe knee OA (experiment 4). This confirms that preserving muscle size is critical
to attenuation of strength deficits in knee OA, however it does not confirm that
atrophy is occurring or that a disuse scenario is responsible for weakness.
Assessment of evoked contractile properties (e.g. twitch properties and modeling of
the torque‐frequency relationship) can provide information about muscle fibre
properties. Decomposition‐enhanced quantitative electromyography (DQEMG)
provides information concerning MU size, recruitment patterns and firing
characteristics. If disuse atrophy is occurring, characteristic changes in evoked
contractile and MU properties should also be observed.
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CHAPTER 2
DEFINITION OF DISEASE SEVERITY INFLUENCES OUTCOME MEASUREMENT IN
PATIENTS WITH KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS
INTITIATIVE
2.0 INTRODUCTION
The relationship between radiographic and clinical features of knee
osteoarthritis (OA) is difficult to define and the literature in this area is equivocal.
Some studies report discordance between the degree of severity of radiographic and
clinical features,15, 26 while others have observed modest‐to‐strong associations.11, 24,
36

The continued examination of the relationship between clinical and radiographic

knee OA is necessary because 1) the definition of disease severity status using a
composite index of pain, structural and functional features has been identified as a
means of developing valid outcome measures for clinical trials,14 2) stratification of
patients in descriptive and randomized studies is commonly performed using
radiographic criteria in isolation or combined with clinical criteria31 and 3) X‐rays
are perceived to be helpful in making management decisions by clinicians.5, 6
Discrepancy between clinical and radiographic categorization of severity for
knee OA has potential negative consequences including adding inappropriate
heterogeneity in the severity of study groups (e.g. severe clinical but mild
radiographic disease) and serving as a confounding variable when considering
clinical management of OA. Duncan et al. reported a moderate relationship between
radiographic disease severity defined by Kellgren‐Lawrence grade (KLG) and
clinical severity measured with the Western Ontario and McMaster Osteoarthritis
Index (WOMAC).11 This suggests that the use of either of these tools to define
24

disease severity states should affect an outcome measure similarly (i.e. the value of
an outcome measure should be similar regardless of disease definition). Others
have reported that KLG is a poor predictor of clinically relevant outcomes, including
WOMAC.4, 10 Therefore, it remains unclear how the definition of disease (i.e.
radiographic vs. clinical) affects the measurement of common outcomes in knee OA
research.
Quadriceps muscle strength is a clinically relevant outcome measure in knee
OA, which has been shown to have a protective effect against pain and loss of
function.23, 25 Furthermore, the likelihood of experiencing quadriceps weakness is
increased in the presence of radiographic disease, although this relationship is not
as consistent as the relationship between weakness, pain and function.3 It is well
known that the quadriceps muscles are weaker in OA compared to healthy‐
contralateral limbs or age‐matched controls.8 For example, quadriceps muscle
weakness was observed across a radiographic spectrum of knee OA, however no
difference in strength was noted between those with KLG =2 and those with KLG >2,
suggesting a possible ceiling effect for this method of disease stratification.27 The
extent of muscle weakness across a clinical spectrum of knee OA has yet to be
assessed. The purpose of this study was to determine whether muscle weakness
occurs across a clinical spectrum of knee OA and whether the definition of knee OA
(clinical vs. radiographic) has an impact on the magnitude of measured weakness. A
secondary purpose was to further examine the relationship between WOMAC and
KLG.
2.1 METHODS

25

Data for the analysis of tibiofemoral (TF) knee OA was obtained from the
public use datasets (version 0.2.2 clinical dataset) of the Osteoarthritis Initiative
(OAI; online at www.oai.ucsf.edu), a multicentre, longitudinal cohort study designed
to identify biomarkers for the development and progression of symptomatic knee
OA. The OAI dataset comprises demographic, clinical and imaging data on 4796
patients (age 45‐79) from four centres. Only baseline data from tibiofemoral (TF)
compartment of native (i.e. non‐replaced) right knees of the progression sub‐cohort
were analyzed in this study. Eligibility for the progression sub‐cohort was based on
the presence of pain, aching or stiffness in or around the knee for at least one month
during the last 12 months and the presence of TF osteophytes (Osteoarthritis
Research Society International atlas, grade ≥ 1),1 on a posterio‐anterior fixed‐flexion
knee x‐ray. A description of the rationale for these criteria and a full list of exclusion
criteria can be found on the OAI website
(www.oai.ucsf.edu/datarelease/OperationsManuals.asp). Other inclusion criteria
were the availability of baseline KLG and completion of three trials of isometric knee
extension testing. After excluding patients failing to meet the inclusion criteria, the
analysis was conducted on 659 participants. Institutional review board approval
was obtained at the participating sites (Baltimore, MD; Columbus, OH; Pittsburgh,
PA, and Pawtucket, RI) and written informed consent was obtained from each
participating subject.
2.1.1 Measurement of clinical severity
WOMAC is a validated questionnaire that is widely used to quantify clinical
severity of knee OA.7 The WOMAC Likert version 3.1 has 24 items and is divided
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into pain, stiffness and function domains. Each item has 5 response options (none,
mild, moderate, severe, extreme) corresponding to scores 0‐4, with higher scores
indicating increasing severity (see Appendix A). In order to compare muscle
strength across a clinical spectrum of OA, WOMAC was used as an independent
variable whereby total score (24 items, total score 0‐96) was used to stratify study
participants into tertiles with the lowest, middle and highest groups representing
mild, moderate and severe knee OA, respectively. In order to compare the
relationship between WOMAC and KLG, WOMAC total score and pain and function
subscale scores (pain: 5 items, total score 0‐20, function: 17 items, total score 0‐68)
were used as dependent variables across a radiographic spectrum of knee OA.
2.1.2 Measurement of radiographic disease severity
KLG was used to assess radiographic severity semi‐quantitatively.13 KLG is
performed using a 5 point scale where 0=no changes, 1=doubtful narrowing of joint
space and possible osteophytic lipping, 2=definite osteophytes, definite joint space
narrowing, 3=moderate multiple osteophytes, definite narrowing of joints space,
some sclerosis and possible deformity of bone contour and 4=large osteophytes,
marked narrowing of joint space, severe sclerosis and definite deformity of bone
contour.19 KL<2 was designated mild OA, KL=2 as moderate OA and KL>2 as severe
OA.12 For the TF analysis, standing PA radiographs were acquired using the fixed‐
flexion protocol, described previously.28 Briefly, bilateral x‐rays were acquired with
the patient standing with knees flexed 20‐30 degrees and feet internally rotated 10
degrees. Patient positioning was fixed using a plexiglass positioning frame
(SyanFlexer, Synarc). Further details can be downloaded at

27

www.oai.ucsf.edu/datarelease/OperationsManuals.asp. Reliability of KLG was
assessed (2 blinded readers) on a subset of the progression cohort with a weighted
kappa=0.88 (95%CI 0.82‐0.94).
2.1.3 Measurement of isometric muscle strength
Participants completed brief isometric knee extension maximal voluntary
contractions (MVC) to measure maximal quadriceps strength. Quadriceps strength
was normalized to body mass to control for sex and body size differences between
groups. The best trial was used to represent maximal strength. Knee extensor
strength in the OAI dataset was assessed with the Good Strength apparatus (Metitur,
Jyväskylä, Finland). Briefly, patients were positioned upright in a chair with test leg
at 60 degrees from full extension. Two submaximal practice trials were completed,
followed by 3 MVCs, each separated by 30 s. A complete description of the protocol
and data collection process can be downloaded at
www.oai.ucsf.edu/datarelease/OperationsManuals.asp.
2.1.4 Statistical analysis
One‐way ANOVA with Tukey’s honestly significant differences test was used
to assess between‐group differences for muscle strength for both clinical and
radiographic disease definitions. The relationship between muscle strength and
WOMAC score was described by the Spearman rank correlation coefficient. The
Kruskal‐Wallis test with post‐hoc Dunn’s multiple comparisons test was used to
determine between group differences for WOMAC total and subscale scores
(excluding stiffness subscale) for radiographic severity. The relationship between
the dependent variable (strength) and possible covariates was determined with
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Pearson correlation coefficient for both datasets. For the OAI dataset, both sex
(r=0.40, p<0.01) and age (r=‐0.21, p<0.01) were significantly correlated with
strength and were therefore tested for their covariate effects. A one‐way
randomized ANCOVA was performed to rule out the possibility that observed
differences in strength between disease severity states were due to covariate effects.
Level of significance was set at p<0.05. All descriptive data are reported using
means ± standard deviation. Statistics were performed with Graphpad Prism
Version 5.0b (La Jolla, CA), except for ANCOVA, which was performed using SPSS
Version 17.0 (Chicago, IL).
2.2 RESULTS
Basic demographic information for all participants is listed in Table 2.1. The
relationship between normalized isometric muscle strength (N/kg) and total
WOMAC score is depicted in Figure 2.1. A significant negative correlation was
observed (r=‐0.31, p<0.05). Mean strength values for clinical and radiographic
predictor variables are listed in Table 2.2. When comparing muscle strength across a
clinical disease spectrum, a significant difference was observed (p<0.05). With post‐
hoc testing, all differences between groups were significant, where strength
differences were; moderate 10.9% lower than mild, severe 11.2% lower than
moderate and 20.9% lower than mild. When KLG of the TF compartment was used
as the predictor variable, a significant difference in strength was observed (p<0.05).
Both moderate (11.2% lower) and severe (8.7% lower) groups were significantly
different than the mild group with post‐hoc testing. After controlling sex and age
covariates, all differences between groups remained significant (p<0.05).
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The values for pain subscale, function subscale and total WOMAC score across a
spectrum of radiographic severity are listed in Table 2.3. A significant difference for
total WOMAC score, and pain and function subscale score was observed. Although
differences were significant there was variability in WOMAC score across
radiographic severity. Coefficients of variation for total WOMAC scores for mild,
moderate and severe OA were 79.3%, 74.6% and 61.6%, respectively.
2.3 DISCUSSION
The results of this study suggest that definition of disease severity influences
the measurement of quadriceps muscle strength and may similarly affect other
clinically relevant outcomes in knee OA research. Furthermore, it appears that there
is a ceiling effect to using KLG as a severity stratification tool, such that differences
in strength between clinically moderate and severe patients were not observed
between radiographically moderate and severe patients. Finally, with increasing
KLG, an increase in WOMAC score (both total and subscale scores) was observed,
although there was substantial variability in WOMAC scores within radiographic
subgroups. This suggests that in a large sample, using KLG should not result in
clinically heterogeneous subgroups although the large variability has implications
for the management of individual patients.
Quadriceps muscle weakness is a common and early finding in patients with
knee OA and its relationship with disability and pain is well established.2, 22, 23, 25
McAlindon et al. reported reduced likelihood of disability in knee OA patients with
better quadriceps strength.23 Subsequently, O’Reilly et al. observed that quadriceps
weakness was independently associated with pain and that there was an increased
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Table 2.1 Patient characteristics.
n
659
Age
61.4±9.0 (45:79)
Height (m)
1.69±0.09 (1.48:1.90)
Weight (kg)
85.5±16.4 (48.8:131.4)
2
Body Mass Index (kg/m ) 29.9±5.0 (19.5:48.7)
Sex (male/female)
289/370
Data are presented as mean ± standard deviation. Data in parentheses indicate
range.
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Table 2.2 Normalized isometric quadriceps muscle strength across clinical and
radiographic spectra of tibiofemoral knee OA. Values for strength are in N/Kg.
Predictor Variable Mild
Moderate Severe
pvalue
†
WOMAC
4.49±1.51 4.00±1.44* 3.55±1.35* <0.05
KLG
4.38±1.59 3.89±1.59* 4.00±1.34* <0.05
WOMAC: Western Ontario and McMaster Osteoarthritis Index; KLG: Kellgren‐
Lawrence grading of the tibiofemoral joint. For the WOMAC predictor variable,
participants were stratified into severity groups based on tertiles of WOMAC score.
For KLG predictor variables KLG<2, KLG=2 and KLG>2 represented mild, moderate
and severe radiographic disease respectively. Data are presented as mean ±
standard deviation.
*Significantly different than mild OA (p<0.05)
†Significantly different than moderate OA (p<0.05)
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Table 2.3 WOMAC scores across tibiofemoral osteoarthritis disease severity
measured by Kellgren‐Lawrence grade.
Predictor Variable KLG<2
KLG = 2
KLG>2
pvalue
Pain
<0.05
3.97±3.47
4.70±3.87
5.20±3.56*
Function
12.25±10.87 15.50±12.76 16.40±11.20* <0.05
Total
<0.05
18.4±14.6
23.1±17.2*
24.7±15.2*
WOMAC: Western Ontario and McMaster Osteoarthritis Index; KLG: Kellgren‐
Lawrence grade.
Data are presented as mean±standard deviation.
*Significantly different than mild OA (p<0.05)
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Figure 2.1 The relationship between total WOMAC score and quadriceps muscle
strength (N/kg) for 659 patients. A significant (p<0.05) negative linear correlation
was observed with r=‐0.31. WOMAC: Western Ontario and McMaster Osteoarthritis
Index.
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likelihood of disability if weakness was present in a pain positive OA group.25 In
both of these studies, weakness was a stronger predictor of pain and/or disability
than the presence of radiographic knee OA. Our observations add to previous
literature given that prior studies defined disease and weakness dichotomously (e.g.
pain present or absent). We observed an association between quadriceps strength
and a continuous measure of disease severity (Figure 2.1). Moreover, WOMAC
represents three separate domains of knee OA allowing for greater construct
validity than measuring associations between strength and disability or knee pain in
isolation.
Stratification of a knee OA study sample using WOMAC scores allowed for
clinically homogeneous subgroups. Thus, it was apparent that quadriceps muscle
weakness occurs across a clinical spectrum of knee OA. While it is well established
that quadriceps muscles in knee OA are weaker than healthy controls or
contralateral knees,8, 16‐18, 21 the progression of quadriceps weakness in knee OA had
not previously been examined from a clinical perspective. From our observations, it
is clear that weakness occurs across a disease spectrum. Conversely, we observed
that although weakness occurred across a radiographic spectrum, there was no
difference in strength between moderate and severe radiographic knee OA.
Palmieri‐Smith reported similarly that the knee extensors of those with KLG ≥ 2
were approximately 20% weaker than a group with KLG <2, however there was no
difference between those with KLG=2 and KLG >2.27 Along with our results, this
implies that there is a ceiling effect to KLG. Consequently, important changes in the
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natural history of knee OA may be obscured when using radiographic disease
definitions. Brandt et al. reported no difference in quadriceps strength between
those with stable versus progressive radiographic knee OA over 2.5 years, however
it is possible that differences were masked by the ceiling effect for radiographic
severity.9 Furthermore, assessing OA clinically may provide information about
optimal type and timing of intervention. Previous research has illustrated that
quadriceps weakness occurs early in the natural history of knee OA and strength
training interventions implemented early may be of benefit.20, 35 Our results suggest
that interventions targeting those with already significant clinical OA could also be
effective. Moreover, the optimal type of intervention may change as the disease
progresses. There is evidence to suggest that muscle weakness in early knee OA may
be from disuse atrophy, while deficits in voluntary activation have been reported in
more severe disease.29, 32 It is unclear if employing different treatment strategies
depending on disease severity may alter relevant outcomes, such as time to joint
replacement.
We also observed that deficits in strength were of a higher magnitude when
patients were stratified clinically. Specifically strength deficits in severe OA
compared to mild were twofold higher when stratifying clinically. This finding is not
surprising considering the tenuous relationship that has been reported between
radiographic findings and quadriceps muscle weakness. Recent reports have
illustrated that quadriceps weakness is not associated with isolated patellofemoral
and tibiofemoral OA in men,3 does not predict incident radiographic OA34 and is not
a risk factor for cartilage loss measured semi‐quantitatively with MRI.2 Therefore, it
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is clear that disease definition influences the measurement of quadriceps strength
deficits in knee OA, such that quadriceps muscle weakness was underestimated
when stratifying with KLG.
Similar to Duncan et al. we observed WOMAC score (both total and subscale
scores) of increasing severity for worsening of KLG.12 An association between these
two commonly used measurement tools supports their utility for disease severity
stratification in large population studies. However, to our knowledge we are the
first to report on the variability of WOMAC scores for individual participants in the
KLG groups. The high coefficients of variation for total WOMAC score (>60%
variation in total WOMAC score for each group) have implications not only for
outcome measurement, but also for individual patient care. Bedson et al. reported
that primary care physicians were less likely to refer patients with knee pain to a
physiotherapist and more likely to refer to an orthopedic surgeon when X‐rays were
positive for knee OA, regardless of clinical severity.6 As the relevance of
radiographic findings to the individual patient is variable, this has the potential to
impact on patient management.
A limitation of this study was the use of ordinal measurement tools for
clinical and radiographic disease severity. In particular, KLG has been criticized
because the magnitude of difference between the grades may not be equal.13
Furthermore, Schipof et al. reported that there is a discrepancy between studies on
how KLG is implemented (e.g. 5/11 studies reviewed in their article defined KLG = 2
as having definite osteophytes), making inter‐study comparison difficult.31 The use
of novel quantitative and semi‐quantitative scoring systems based on MRI of the
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knee joint is becoming increasingly popular and is more sensitive to structural
progression than plain films.37 It may be that WOMAC is better correlated with MRI
measures of disease incidence and progression, although some studies have
reported weak or no associations.30, 38 Moreover, many of these measurement tools
have yet to be validated in clinical studies, and the use of radiographs for disease
stratification and as an outcome measure is still widespread.
A further limitation is that data in this study are limited to the TF
compartment. Associations have also been observed between KLG for the
patellofemoral (PF) compartment and WOMAC12 and it is possible that quadriceps
muscle strength is affected to a greater degree in PF disease. Large population
studies have observed significant associations between quadriceps muscle
weakness and progression2, 33 of PF OA, particularly of the lateral PF compartment.
A potential mechanism has also been postulated whereby weak quadriceps
(particularly the vastus medialis) allows for lateral tracking of the patella during
activity.33 The relationships between clinical and radiographic measures observed
in our study may have been stronger and less variable if PF OA was incorporated
into the analysis.
In conclusion, we observed that clinical, as opposed to radiographic
measures for disease severity stratification may be more valid when measuring
clinically relevant outcomes, such as quadriceps muscle weakness in patients with
knee OA. Furthermore, using radiographic criteria in isolation may distort the
natural history of quadriceps weakness in knee OA. Additionally, the variability in
clinical severity in those with mild, moderate and severe radiographic knee OA
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brings into question the utility in making treatment decisions based on radiographic
findings alone.
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CHAPTER 3
QUADRICEPS STRENGTH, POWER AND MUSCLE QUALITY ACROSS A CLINICAL
SPECTRUM OF KNEE OA
3.0 INTRODUCTION
The quadriceps muscles of patients with knee osteoarthritis (OA) are weak in
comparison with the less affected contralateral limb or age‐matched control limbs.6
Weak quadriceps muscles show a higher degree of association with mobility
impairments than radiographic evidence of cartilage degeneration21, 26 and may be a
risk factor for disease incidence and progression.29, 32, 35 Despite its clinical
relevance, the magnitude and mechanisms of quadriceps muscle weakness in knee
OA have not been fully characterized.
Studies of muscle function report a 20‐40% reduction in quadriceps muscle
strength in knee OA for isometric and isokinetic contractions.6, 13, 14, 16, 18, 19, 23, 34 The
type of design utilized in these studies does not provide information about the
severity of muscle weakness across a clinical spectrum of disease. Commonly, knee
OA is defined dichotomously (i.e. present or absent) using radiographic scoring such
as Kellgren‐Lawrence grading (KLG), with KLG ≥ II representing presence of OA.
The validity of using radiographic features is limited when considering the
discrepancy that exists between clinical and radiographic features of knee OA.4
Consequently, if radiographic criteria alone are used to define knee OA, a clinically
heterogeneous study sample will be produced that may lead to underestimation of
muscle weakness, particularly in those with clinically severe disease.
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The way in which strength is measured may also impact studies aimed at
determining the extent of weakness in knee OA. Quadriceps muscle power, the
product of torque and velocity of movement, has yet to be assessed in patients with
knee OA. Recent evidence suggests that power declines more precipitously than
strength and is a more robust predictor of functional outcomes in healthy older
compared to younger adults, presumably because most activities of daily living
require a combination of adequate torque and velocity.2, 9, 11, 27, 31 Additionally,
rehabilitation of muscle power deficits may be optimized with power or velocity
specific resistance training.3, 7 It is unknown whether quadriceps power deficits
exist in those with knee OA and if function could be improved with power specific
rehabilitation. Therefore, the purpose of this study was to determine whether
quadriceps muscle strength and power differ across a clinical spectrum of severity
in knee OA. In order to elucidate the mechanism of muscle weakness, strength and
power were normalized to MRI‐derived measures of quadriceps volume to provide
an index of muscle quality (i.e. specific torque and specific power).36
3.1 METHODS
3.1.1 Study participants
Forty‐one community dwelling men and women, recruited from local
orthopedic outpatient clinics, volunteered to participate in the study. Participants
were included if they had persistent knee pain that resulted in referral to an
orthopedic surgeon and/or X‐ray findings consistent with knee OA in at least one
compartment (e.g. presence of osteophytes, apparent joint space narrowing,
subchondral sclerosis and areas of cyst formations) confirmed by an experienced

46

musculoskeletal radiologist or orthopedic surgeon. All participants met the
American College of Rheumatology criteria for knee OA.1 Exclusion criteria included
musculoskeletal, neurological or rheumatological impairment of the lower limbs
other than knee OA, prior high tibial osteotomy, unicondylar or total knee
arthroplasty or cardiopulmonary impairment that precluded performing vigorous
muscle contractions. If a patient had bilateral knee OA, the limb with the more
severe symptoms (as reported by the patient), was selected as the test limb. Ethical
approval for the study was obtained from the Human Research Ethics Board at the
University of Western Ontario and written consent was obtained from each
participant prior to study commencement.
Participants were stratified into tertiles of disease severity based on their
responses to the Western Ontario and McMaster Osteoarthritis Index (WOMAC).
WOMAC is a validated, widely used tool to quantify clinical severity in knee OA
patients.5 The lowest, middle and highest tertiles were designated mild, moderate
and severe knee OA respectively.
3.1.2 Experimental setup and test protocol
Participants were seated upright in a multi‐joint dynamometer (Biodex
System 3, Shirley, NY), with knee and hip angles of 90° and 100° respectively. The
centre of rotation of the knee was aligned with the axis of rotation of the
dynamometer’s lever arm. The force transducer was positioned with its bottom
edge two fingerbreadths proximal to the medial malleolus of the test leg and fixed
with a Velcro strap. A seat‐belt strap was positioned across the lap in order to avoid
unwanted movement of synergist hip flexors during quadriceps contractions. The
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test protocol commenced with a series of submaximal isometric contractions
(approximately 50‐75% of maximal intensity) for the purposes of warm‐up and
familiarization. Participants then performed repeated, brief (~5 s) isometric
maximal voluntary contractions (MVCs) of the quadriceps (3‐5 repetitions), each
separated by a minimum of 90 s of rest. Maximal contraction intensity was
determined when two consecutive MVCs differed by less than 5%. The highest MVC
torque was utilized as the value for maximal isometric strength and to normalize
submaximal torque during subsequent isotonic power testing.
To investigate torque‐velocity and torque‐power relationships, participants
performed a series of submaximal isotonic concentric quadriceps contractions
through a 90° range of motion, at maximum speed. Range of motion was tailored to
each individual participant such that 90° from their full extension range was used as
the starting point for contraction. Submaximal loads set at 10, 20, 30, 40 and 50% of
isometric MVC were programmed in a random order using the Biodex Isotonic
Mode. An additional intensity level with a load of 1 N•m (the minimum load added
to the resistance of the force transducer) was performed to determine power and
velocity at the lowest possible load (i.e. Zero Load). For each contractile intensity,
participants were instructed to move through the concentric phase as quickly as
possible and allow for passive return to the initial position. Immediately thereafter
a second contraction was performed at that same load. Peak velocity and the load
programmed into the dynamometer at each intensity level were used to calculate
isotonic power. Multiple practice contractions were performed at Zero Load for
familiarization prior to the test. A 1 min. rest period separated each load. Loud
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verbal encouragement and visual feedback using the real‐time digital torque and
velocity tracings were used during all contractions to ensure maximal intensity and
velocity. At least 10 min. rest separated the protocols for measuring isometric
strength and power to allow for appropriate recovery.
3.1.3 Magnetic resonance imaging of quadriceps muscle volume
MRI scans of the thigh were acquired using a 3.0T MR system (GE Discovery
MR750, GE Healthcare, Waukesha, Wisc.) with an 8‐coil torso phased array. The
patient was positioned supine in the scanner bore. A 3‐plane localizing scan and
calibration scan were performed to ensure the anatomy of interest was contained in
the field‐of‐view (FOV). Three‐dimensional axial images were acquired from
proximal (femoral head) to distal (femoral condyles) with a proton density weighted
multiecho‐spoiled gradient echo (SPGR) imaging sequence (FOV: 42‐46x21‐23 cm,
slice thickness: 4 mm, matrix: 320x160x120, TR: 7.4 ms, echoes: 6, TE, 1.4, 2.1, 2.9,
3.6, 4.4, 5.1 ms, flip angle 5°, bandwidth: ± 142.86 kHz). An investigational version
of the IDEAL (iterative decomposition of water and fat with echo asymmetry and
least squares estimation) multipoint water‐fat separation method that is T1
independent, T2* corrected and employs accurate spectral modeling of fat, was used
to reconstruct both water‐only and fat‐only images from the multiecho SPGR source
images.28, 38 Fat‐water separation also ensured that non‐muscle tissue (in particular
fat) was not included in analysis of the thigh images. Image analysis was performed
on the water only images produced by the IDEAL reconstruction for assessment of
muscle volume.
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A combination of manual and semi‐automated techniques using open‐source
OsiriX image processing software (version 3.7, Geneva, Switzerland) was used to
analyze images and calculate muscle volume. Analysis began proximally from the
first slice not containing the gluteal muscle to the last distal slice containing the
rectus femoris, as this region is thought to represent maximal thigh muscle mass37
and because it is difficult to differentiate between thigh muscles at the most
proximal and distal slices.8 Quadriceps muscle volume was calculated from the
water‐only images by manually outlining the most proximal and distal slices with
the brush tool to create regions of interest (ROI). This process was repeated for
every tenth slice in‐between and missing ROIs were generated automatically. Once
the quadriceps had been roughly outlined, all pixel values outside the ROIs were set
to zero. Subsequently, a 3D threshold‐growing tool was used to grow ROIs for the
quadriceps muscle tissue only from a defined seedpoint within the muscle. This was
done to ensure exclusion of non‐muscular tissue in the septal spaces. Any errors
produced by the automatic tool were corrected manually. The software
automatically calculated volume for the series of ROIs. The reliability of this method
defined by the intraclass correlation coefficient (ICC; 2,1) and 95% confidence
intervals was high (intra‐rater: ICC=0.997, 0.991‐0.999 and inter‐rater: ICC=0.997,
0.988‐0.999 based on 16 and 11 cases, respectively). Thigh images from
representative male subject in the mild and severe group are presented in Figure
3.1.
3.1.4 Data reduction and statistics
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Figure 3.1 Axial view of the mid‐region of the right thigh for representative male
subjects from the mild (a) and severe (b) disease subgroups. The four bellies of the
quadriceps are labeled VM (vastus intermedius), RF (rectus femoris), VI (vastus
intermedius) and VL (vastus lateralis).
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Torque and position were sampled at 100 Hz, AD converted with a 12‐bit
converter (CED micro1401 mk II, Cambridge Electronic Design Limited, Cambridge,
UK) and displayed in real‐time on an online digital system using commercially
available software (Spike2 ver. 5, Cambridge Electronic Design). During offline
analysis, power for each submaximal load was calculated as the product of torque
(N•m) and peak velocity generated during the contraction (rad/s). Torque and
power were normalized to body mass to account for body size differences among
participants.
A one‐way ANOVA with a post‐hoc Tukey’s test was used to compare
participant characteristics and strength measures between severity states. A two‐
way ANOVA with a post‐hoc Bonferonni Correction was used to compare velocity,
power and specific power across loads (main effect 1) and disease severity (main
effect 2). MRI‐derived measures of muscle volume were not available for 4
participants in the moderate group (1 female, 3 male) and one participant in the
severe group (1 male) due to contraindication to MRI (e.g. claustrophobia, presence
of metallic objects). In order to account for these missing values, the software
program converts the ANOVA problem to a multiple regression problem and then
displays the results as ANOVA. The data were collapsed across disease subgroups
and univariate linear regression models were used to determine the predictive
value of strength, velocity and power measures to self‐reported function (WOMAC
function subscale). Multivariate regression was not employed as all of the
independent variables were collinear. All descriptive statistics are presented as
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mean ± standard deviation. Level of significance was set at p<0.05. All statistical
tests were performed with Graphpad Prism Version 5.0b (La Jolla, CA).
3.2 RESULTS
Participant characteristics, including WOMAC score, maximal isometric
torque and muscle volume are presented in Table 3.1. No significant difference was
observed for age and body mass index (BMI) between groups (p>0.05). Significant
differences were observed for height and body mass (p<0.05). After post hoc
testing, patients in the moderate group were taller and had greater body mass than
those in the severe group and patients in the mild group had significantly less body
mass than those in the moderate group. Significant differences were observed for
WOMAC score, absolute isometric torque, normalized isometric torque and muscle
volume (Table 3.1, p<0.05). Post hoc testing revealed that all subgroups differed
significantly from each other with respect of WOMAC score (p<0.05). Post hoc
significant differences in normalized isometric strength between mild and severe
groups were also observed, with mean strength ~36% lower in the severe group.
No significant difference was observed between mild and moderate and moderate
and severe groups for normalized isometric strength (p>0.05) .
A significant main effect for disease severity was observed for both torque‐
velocity and torque‐power (normalized to body mass) relationships (Fig. 3.2,
p<0.05). Post hoc testing revealed that velocity at Zero Load, 10% and 20% MVC
was lower in the severe group compared to both mild and moderate groups (Fig.
3.2a). Additionally, velocity at 30% MVC was lower in the severe compared to mild
group. The largest difference between mild and severe groups occurred at 20%
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Table 3.1 Participant characteristics (n = 41).
Mild
Moderate Severe
Sex (M/F)
8/5
8/6
6/8
Age
61.1±8.2
58.6±5.3
61.8±4.3
Height (m)
1.67±0.10 1.74±0.09* 1.66±0.05
Weight (kg)
78.8±11.2† 99.1±7.4*
84.9±15.4
BMI (kg/m2)
28.2±3.9
32.7±5.6
30.8±5.4
Total WOMAC score
17.5±8.5*† 40.1±6.5*
61.2±7.7
Isometric torque (N•m)
177±76*
189±80*
120±52
Normalized isometric torque (N•m/kg) 2.19±0.83* 1.94±0.74 1.42±0.49
Muscle volume (cm3)
909±334
1019±324* 670±214
Data are presented as means ± standard deviations. BMI: body mass index.
*Significantly different than severe with post‐hoc testing (p<0.05).
†Significantly different than moderate with post‐hoc testing (p<0.05).
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pvalue
0.37
<0.05
<0.05
0.08
<0.05
<0.05
<0.05
<0.05

Table 3.2 Coefficients of determination (r2) for univariate regression models using
WOMAC function subscale as the dependent variable.
Coefficient of Determination (r2) Pvalue
0.01
Isometric Strength (N•m/kg) 0.14
Power (N•m•rad/s/kg):
Zero Load
0.27
<0.001
10% MVC
0.16
0.009
20% MVC
0.19
0.005
30% MVC
0.17
0.007
40% MVC
0.12
0.03
50% MVC
0.12
0.03
MVC: maximal voluntary contraction.

56

Figure 3.2 Velocity (a) and power normalized to body mass (b) at Zero Load, 10%,
20%, 30%, 40% and 50% MVC. Participants were stratified by WOMAC score into
mild (triangle), moderate (square) and severe (circle) subgroups. Zero Load: load
equal to 1 N•m combined with the mass of the dynamometer foot‐plate; WOMAC:
Western Ontario and McMaster Osteoarthritis Index; MVC: maximal voluntary
contraction.
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Figure 3.3 Quadriceps torque (a) and power (b) for mild (triangle), moderate
(square) and severe (circle) knee OA, normalized to MRI‐derived measures of
muscle volume (i.e. specific torque and specific power). Zero Load: load equal to 1
N•m combined with the mass of the dynamometer foot‐plate; MVC: maximal
voluntary contraction.
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MVC where velocity was 23% lower in the severe group. Differences in isotonic
power were also observed between the mild and severe groups only, after post
hoctesting (Fig. 3.2b). Power was lower at 20%‐50% MVC (45‐50% lower with the
greatest difference occurring at 20% MVC). It should be noted that peak power
(contractile intensity at which velocity and torque are optimized) in this study
occurred at 40% MVC. Muscle quality as determined by specific torque was not
significantly different between groups (Fig. 3.3a), nor was specific power at any
contractile intensity level (Fig. 3.3b, p>0.05).
WOMAC function subscale was used as the measure of self‐reported
disability in this study. Individual, univariate linear regression models yielded
coefficients of regression for the relationship between function and measures of
muscle strength and power (Table 3.2). Power measured at Zero Load explained the
largest proportion of the variance in function compared to power measured at 40 %
and 50% MVC, which explained the lowest proportion of variance.
3.3 DISCUSSION
The results of this study have implications for future study design,
rehabilitation and further understanding of the mechanisms of neuromuscular
dysfunction in knee OA. By defining disease severity using clinical criteria, we
observed a reduction in normalized quadriceps strength in severe compared to mild
knee OA. Furthermore in this first investigation of isotonic muscle power, it was
observed that normalized quadriceps power across a range of contractile intensities
was reduced in severe knee OA. Additionally, the deficits in power were greater
than those observed for strength. As the reduction in power was not accompanied
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by a change in whole muscle quality (measured with specific torque and specific
power) it is reasonable to suggest that power deficits may be due to differences in
muscle fibre size, particularly of the type II, fast twitch muscle fibres. Finally, power
deficits (in particular power measured at the lower loads) explained more of the
variance in self‐reported function than isometric strength, suggesting that these
deficits should be addressed in order to attenuate disability in knee OA patients.
The observation that isometric strength in the severe group was ~36% lower
than the mild group is similar to the magnitude of strength deficits reported by
others in this patient population (for a review see reference 6). However, knee OA is
usually defined dichotomously (i.e. presence or absence) based on radiographic
criteria such as KLG and this could lead to heterogeneous disease subgroups and an
underestimation of muscle weakness. There are currently no universally accepted
criteria encompassing the clinical, radiological and pathological features of knee OA
available to designate disease severity states.12 Furthermore, the tenuous
relationship between radiographic disease markers and symptoms has been well
documented.4 Consequently, in our study patients were stratified into tertiles of
disease severity based on WOMAC scores. While this method certainly has its
limitations (see below), it revealed that muscle weakness is not homogeneous in all
patients with knee OA. Furthermore, the strength deficit in those with severe knee
OA has implications for rehabilitation, as it has been reported that quadriceps
weakness predicts poor function after total knee arthroplasty.25 It should also be
noted that the strength deficits observed in this study were likely not attributable to
patient characteristics (Table 3.1). Subgroups were reasonably well matched for

62

sex, age and body size and strength was normalized to body mass.36 Those in the
moderate group were taller and heavier than those in the other groups, however
this did not affect the observed strength differences (i.e. moderate group did not
display differences in normalized strength and power compared to mild or severe
groups).
To our knowledge this is the first study to report reductions in quadriceps
isotonic velocity and power at a range of contractile intensities in those with severe
knee OA. Isotonic rather than isokinetic contractions were used because they are
more functionally relevant22 and because severely impaired participants may not be
able to achieve the velocities required during high velocity contractions.17 While
this is a novel finding in participants with knee OA, certain parallels can be drawn to
similar observations in healthy older adults. Studies of healthy elders report that
power deficits compared to young subjects occur more precipitously and are of
greater magnitude than strength deficits.24, 33 In our study, deficits in power at 20‐
50% MVC contractile intensities (~45‐50% reduction in power) in the severe versus
mild group were of greater magnitude than deficits in isometric strength.
Furthermore, the greatest deficit occurred at 20% MVC. This is of significance
because activities of daily living (e.g. walking, ascending/descending stairs etc.) are
rarely performed at or near maximal contractile intensities, but require adequate
power at these lower contractile intensities. Therefore, impaired quadriceps
function at submaximal intensities may have greater implication for functionality.
In addition to deficits in speed and power, deficits have also been reported in
proprioception and the ability to control force output at submaximal contractile
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intensities,13 indicating the possibility of widespread neuromuscular dysfunction in
this population. These deficits have implications for rehabilitation. Specifically, it is
unknown if interventions targeting power deficits would have a greater effect on
attenuating disability. Specific power or velocity training has been shown to result
in greater improvements in muscle outcomes in some,3, 7 but not all30 studies of
healthy older participants.
Based on our results we can also make inferences about the mechanisms of
strength and power deficits in the quadriceps in knee OA. The traditional paradigm
of weakness in knee OA is one of muscle fibre atrophy due to disuse induced by a
painful knee joint.15 Normalization of quadriceps torque and power to MRI‐derived
measures of muscle volume allowed for measurement of differences in muscle
quality independent of muscle size. We observed no differences in specific torque or
specific power across groups, suggesting that muscle mass is predominantly
responsible for reduced muscle strength and power in the severe compared to mild
group, thus substantiating the model of disuse atrophy. This is in contrast to whole
muscle and individual fibre studies of healthy older compared to younger
participants showing that specific torque and power are reduced.36 Reduced
number of sarcomeres in series, changes in the function of myosin heavy chain
ATPase enzyme and reductions in neural activation may explain the reductions in
muscle quality observed in these studies of healthy elders, however similar muscle
quality across groups in our study suggests no such changes are occurring across a
clinical spectrum of knee OA. It is interesting to note that reductions in velocity
were only significant at the lowest contractile intensities and reductions in power
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significant only at the highest contractile intensities. Based on these results, it is
possible that the type II, fast twitch muscle fibres are preferentially involved in the
atrophy process. Type II muscle fibres are usually recruited for fastest and or
highest intensity contractions. This notion is supported in a study by Fink et al. in
which the vastus medialis muscles of knee OA patients were biopsied peri‐
operatively (during total knee arthroplasty) and preferential type II fibre atrophy
was observed in conjunction with evidence of fibre type grouping (indicative of a
collateral reinnervation process).10 This hypothesis requires confirmation in
longitudinal studies.
In univariate linear regression models, power measured at the lowest
contractile intensities was a stronger predictor of the variance in self‐reported
function than isometric strength (Table 3.2). In particular, power measured at Zero
Load explained almost double the variance explained by MVC strength. Similarly,
there is evidence to suggest that power is a more robust predictor of function than
strength in healthy elderly subjects. Bean et al. reported that leg extensor peak
power measured in older adults with mobility limitations explained a greater degree
of variance in performance on the Short Physical Performance Battery than
strength.2 It is interesting that power at zero load and not peak power (i.e. the point
where both velocity and torque are optimized) was the strongest predictor of
subjective function. A reduction in the velocity component of power may be an
independent predictor of function. Mayson et al. reported that maximal leg extensor
velocity was a stronger predictor of balance than strength.20 Intuitively, reductions
in power at the lowest contraction intensities should be more detrimental to
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function, since many activities of daily living are performed at higher contraction
velocities with low‐to‐moderate loads (e.g. gait velocity, prevention of falling etc.).
There are limitations to the interpretation of these results. First, no
differences in strength and power were observed between the moderate group and
other disease subgroups. Stratifying participants into cross‐sectional severity states
using an ordinal scale is not without limitations. As the WOMAC cutoffs used to
define the disease subgroups were arbitrary, it is conceivable that many participants
in the moderate group with borderline WOMAC scores would have been in either
the mild or severe groups. This limitation in study design may have masked
clinically relevant differences between mild and moderate knee OA. Another
limitation is that measures of function in this study were self‐reported. It is
unknown if the relationships between strength, power and function would persist
or be more robust with objective functional outcome measures.
In conclusion, strength, velocity and power were lower in those with
clinically defined severe, compared to mild knee OA. The deficits in strength and
power were not accompanied by changes in muscle quality, suggesting that muscle
atrophy, particularly of the type II muscle fibres is predominantly responsible for
quadriceps muscle weakness. Furthermore, deficits in power, especially at low
contraction intensities may be more robust predictors of disability in this patient
population. Further investigation into the impact of improving quadriceps velocity
and power on functional outcomes is warranted.
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CHAPTER 4
QUADRICEPS SIZESTRENGTH RELATIONSHIPS IN PATIENTS WITH KNEE
OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE

4.0 INTRODUCTION
Quadriceps muscle weakness in patients with knee osteoarthritis (OA) has
been attributed to atrophy secondary to joint pain and/or disuse.4 Accordingly, a
relationship should exist between quadriceps muscle strength and size in this
clinical population, as muscle size has been shown to be the primary determinant of
strength in studies of aging,8 resistance training27 and sex differences.21 However, in
a study of patients with severe unilateral knee OA (Kellgren‐Lawrence Grade,
KLG=IV), quadriceps muscle size was only weakly correlated with isometric
maximal voluntary contraction (MVC, r2=0.27).22 Furthermore, the relationship
between quadriceps muscle strength and size (i.e. the size‐strength relationship)
has been shown to vary in studies of healthy young and older individuals.1, 10, 28
Inter‐study variability could arise for a number of reasons. First, the
quadriceps size‐strength relationship in knee OA may be affected by the definition of
disease severity. Knee OA is usually defined dichotomously (i.e. presence vs.
absence) using radiographic criteria, resulting in OA groups comprising patients
with both mild and severe disease. Furthermore, the relationship between symptom
severity and radiographic change is tenuous.2 Consequently, those with severe
radiographic disease may have variable clinical presentation. It is unknown
whether the size‐strength relationship is altered across a clinical spectrum of knee
OA. Second, methodological differences in the measurement of muscle size may
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affect the size‐strength relationship. Muscle size can be measured with a variety of
imaging or anthropometric techniques, although magnetic resonance imaging (MRI)
is the gold standard as contrast allows for non‐muscle tissue to be excluded from the
image analysis and unlike computed tomography, there is no exposure to ionizing
radiation.6 The parameter used to represent muscle size may also be variable and
can range from whole muscle volume to single slice anatomical or physiological
cross‐sectional area. For example, it is common to image a small section of the thigh
or to report the anatomical cross sectional areas (ACSA) of a single slice from MRI
scanning in order to estimate thigh volume, as MRI acquisition time for the entire
thigh may be long and segmentation of the whole muscle can be time consuming.20
However, muscle volume estimation from single slice ACSA is associated with a
certain degree of error, depending on the region of the thigh the slice is acquired
from.7, 19, 25 Muscle volume may be a more appropriate index of muscle size when
evaluating size‐strength relationships,1, 5 however volume error is inversely
proportional to the number of slices used in the analysis; therefore imaging only a
small section of the thigh may result in inaccurate muscle size measurement.18, 20, 25
The quadriceps muscle size‐strength relationship has yet to be thoroughly examined
in knee OA and it is unknown if the relationship is affected by the method of muscle
size estimation.
The primary objective of this study was to examine the nature of the
quadriceps size‐strength relationship in patients with knee OA and to determine if
this relationship is influenced by clinical disease severity or by different indices of
muscle size. Because the validity of muscle size measurements may also be
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influenced by the MRI protocol and segmentation methods, a secondary objective
was to determine the effect of inter‐study differences in MRI protocol and
segmentation parameters on the quadriceps size‐strength relationship.
4.1 METHODS
Two separate datasets were used in this study. The primary objective was
addressed using thigh images acquired as part of a comprehensive study of
neuromuscular function in knee OA (herein referred to as local participants). The
secondary objective was addressed using additional thigh images from the public
use datasets of the Osteoarthritis Initiative (OAI, version 0.2.2 clinical dataset,
version 0.E.1 imaging dataset; online at www.oai.ucsf.edu).
4.1.1 Study participants
Thirty‐six community‐dwelling male and female individuals (ages 46‐74),
recruited from local orthopedic outpatient clinics, volunteered to participate in the
study and comprised the local patient population. Participants were included if they
had persistent knee pain that required referral to an orthopedic surgeon and/or X‐
ray findings consistent with knee OA in at least one compartment (e.g. presence of
osteophytes, apparent joint space narrowing, subchondral sclerosis and areas of
cyst formations). Exclusion criteria were musculoskeletal, neurological or
rheumatological impairment of the lower limbs other than knee OA, prior high tibial
osteotomy, unicondylar or total knee arthroplasty, contraindication to MRI or
cardiopulmonary impairment that precluded performing vigorous muscle
contractions. Strength testing and image segmentation were performed on the
symptomatic limb only. If a patient had bilateral knee OA, the limb with the most
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severe symptoms (as reported by the patient), was selected as the test limb. Ethical
approval for the study was obtained from the local institutional ethics review board
and written consent was obtained from each participant prior to study
commencement.
To address the secondary objective, thigh images from a sample of 31 male
and female participants selected at random from both the incident (5 patients) and
progression (26 patients) subcohorts of the OAI were analyzed. Participants in the
incident subcohort did not have symptomatic knee OA at baseline but did have 2 or
more risk factors for knee OA as previously defined. Participants in the progression
subcohort had symptomatic and radiographic OA in the right knee. A description of
the rationale for inclusion in these subcohorts and a full list of exclusion criteria is
available on the OAI website
(www.oai.ucsf.edu/datarelease/OperationsManuals.asp).
4.1.2 MRI of the thigh
MRI scans of the thigh were acquired in the local participants using a 3.0T
MR system (GE Discovery MR750, GE Healthcare, Waukesha, Wisc.) with an 8‐coil
torso phased array. The patient was positioned supine and feet first in the scanner
bore. A 3‐plane localizing scan and calibration scan were performed to ensure the
anatomy of interest was contained in the field‐of‐view. Three‐dimensional axial
images were acquired from proximal (femoral head) to distal (femoral condyles)
with a proton density weighted multiecho‐spoiled gradient echo (SPGR) imaging
sequence (FOV: 42‐46x21‐23 cm, slice thickness: 4 mm, matrix: 320x160x120, TR:
7.4 ms, echoes: 6, TE, 1.4, 2.1, 2.9, 3.6, 4.4, 5.1 ms, flip angle 5°, bandwidth: ± 142.86
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kHz). An investigational version of the IDEAL (iterative decomposition of water and
fat with echo asymmetry and least squares estimation) multipoint water‐fat
separation method that is T1 independent, T2* corrected and employs accurate
spectral modeling of fat, was used to reconstruct both water and fat images from the
multiecho SPGR source images.24 A fat‐water separation was used to ensure that
non‐muscle tissue (in particular fat) was not included in analysis of the thigh
images. Image analysis was performed on the water only images produced by the
IDEAL reconstruction for assessment of muscle size parameters.
For the OAI dataset, axial T1‐weighted scans of the thigh were acquired at
3.0T (Siemens 3.0T Trio Systems). A full description of the rationale and protocols
for thigh MRI for the OAI is available at
www.oai.ucsf.edu/datarelease/OperationsManuals.asp. Briefly, participants were
positioned in a supine position with legs aligned neutrally. The apex of the right
patella was palpated and the mid‐thigh region was defined by measuring to a point
15 cm proximal. A biplanar (coronal‐axial) T1‐weighted, localizing scan was
performed. From the localizer, the distal femoral epiphyseal line was visualized and
the first axial T1‐weighted slice was acquired 10 cm proximal from this point. A 7.5
cm region of 15 contiguous axial slices of the thigh was acquired with the following
sequence parameters: FOV: 500 mm, slice thickness: 5 mm, matrix: 384 x 512, TR:
600 ms, TE/TI: 13 ms, flip angle: 180°, bandwidth: ±199 Hz/pixel.
4.1.3 Segmentation methods
Segmentation of quadriceps muscle for calculation of muscle volume and
ACSA was performed with two different segmentation methods. A combination of
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manual and semi‐automated techniques using open‐source OsiriX image processing
software (version 3.7, Geneva, Switzerland) was used to analyze images from both
datasets (local and OAI). Analyses of the images from the local participants began
proximally from the first slice not containing the gluteal muscle to the last distal
slice containing the rectus femoris, as this region is thought to represent maximal
thigh muscle mass26 and because it is difficult to differentiate between thigh muscle
at the most proximal and distal slices.7 Quadriceps muscle volume was calculated
from the water‐only images by manually outlining the most proximal and distal
slices with the brush tool to create regions of interest (ROI). This process was
repeated for every tenth slice in‐between and missing ROIs were generated
automatically. Once the quadriceps had been roughly outlined, all pixel values
outside the ROIs were set to zero. Subsequently, a 3D threshold‐growing tool was
used to grow ROIs for the quadriceps muscle tissue only from a defined seedpoint
within the muscle. This was done to ensure exclusion of non‐muscular tissue in the
septal spaces. Any errors produced by the automatic tool were corrected manually
by one trained segmenter. The software automatically calculated volume for the
series of ROIs and ACSA for each slice analyzed. Two parameters were used from
images in the local participant dataset to estimate muscle size; 1) total muscle
volume and 2) mid‐thigh ACSA (defined as the middle slice between the first slice
including the femoral head and the last slice containing the lateral femoral condyle).
This corresponded to a mean of 39.9±6.0 slices/patient included in measures of
muscle volume (range: 30‐51). In the OAI dataset, muscle volume estimates were
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Figure 4.1 Axial thigh slices of representative subjects from the local participant
dataset (a) and the OAI dataset (b).
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based on the segmentation of all 15 available slices. Segmented thigh images from
representative subjects for each imaging sequence are presented in Figure 4.1.
To compare the effect of segmentation technique, a separate operator
analyzed the OAI images using a different commercially available software program
(SliceOmatic 4.3, Tomovision, Magog, Quebec) which divides images into small
regions based on the boundaries created by a watershed technique with thresholds
set at 1 pixel surface and 0.01% mean difference. On each slice, quadriceps muscles
were identified and tagged a specific colour. Fat within the muscle (intramuscular
fat) was included in the segmentation of the muscle as the software program was
not sensitive enough to separate it from muscle tissue. The morphological
segmentation of the first analyzed slice was propagated forward to the next 14
slices. Single slice cross‐sectional area was multiplied by slice thickness to obtain a
volume measurement.
4.1.4 Measurement of isometric strength
For analyses of the primary objective, isometric knee extensor strength for
the local participants was measured using a multi‐joint dynamometer (Biodex
System 3, Shirley, NY). Participants were seated upright with knee and hip angles of
90° and 100°, respectively. The centre of rotation of the knee was aligned with the
axis of rotation of the dynamometer’s lever arm. The force transducer was
positioned with its bottom edge two fingerbreadths proximal to the medial
malleolus of the test leg and fixed with a Velcro strap. A seat‐belt strap was
positioned across the lap in order to avoid unwanted movement of synergist hip
flexors during quadriceps contractions. Additionally, during all contractions,
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participants were instructed to fold their arms across the chest and to avoid multi‐
joint movement.
The test protocol commenced with a series of submaximal isometric
contractions (approximately 50‐75% of maximal isometric voluntary contraction;
MVC) for the purposes of warm‐up and familiarization. Participants then performed
repeated, brief (~5 seconds) MVCs of the quadriceps (3‐5 repetitions), each
separated by a minimum of 90 seconds of rest. Maximal contraction intensity was
attained when two consecutive MVCs differed by less than 5%. Torque was sampled
at 100 Hz, AD converted with a 12‐bit converter (CED micro1401 mk II, Cambridge
Electronic Design Limited, Cambridge, UK) and displayed in real‐time on an online
digital system using commercially available software (Spike2 ver. 5, Cambridge
Electronic Design). Loud verbal encouragement and visual feedback using the real‐
time digital torque was provided during all contractions in an attempt to obtain
maximal effort.
For the OAI analysis, all participants were required to complete 3 trials for
isometric knee extension testing. Knee extensor strength was assessed with the
Good Strength apparatus (Metitur, Jyväskylä, Finland). Briefly, participants were
positioned upright in a chair with test leg at 60 degrees from full extension. Two
practice trials were completed at 50% MVC, followed by 3 MVCs, each separated by
30 seconds. A complete description of the protocol and data collection process can
is available www.oai.ucsf.edu/datarelease/OperationsManuals.asp. To compare the
strength measure to quadriceps muscle volume, knee extensor torque was
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calculated as the product of force and moment arm (length measured from the force
transducer to the joint line).1
4.1.5 Measurement of disease severity
Self‐reported disease severity was measured with the Western Ontario and
McMaster Osteoarthritis Index (WOMAC). WOMAC is a validated questionnaire that
is widely used to quantify clinical severity of knee OA.3 The WOMAC Likert version
3.1 has 24 items and is divided into pain, stiffness and function domains. Each item
has 5 response options (none, mild, moderate, severe, extreme) corresponding to
scores 0‐4, with higher scores indicating increasing severity. In order to compare
the size‐strength relationship across a clinical spectrum of OA, WOMAC was used as
an independent variable whereby total score (24 items, total score 0‐96) was used
to stratify study participants into tertiles with the lowest, middle and highest groups
representing mild, moderate and severe knee OA, respectively.
4.1.6 Statistics
The relationships between measures of muscle size and isometric muscle
strength were analyzed with univariate linear regression models and described with
the coefficient of determination (r2). Inter and intra‐rater reliability of each
quadriceps segmentation method was determined using a two‐way random, single
measure intraclass correlation coefficients (ICC 2,1) with 95% confidence intervals
(ICC; SPSS v.17.0, Chicago, IL). Differences in demographic characteristics between
disease severity subgroups were analyzed with a one‐way ANOVA with post hoc
Tukey’s honestly significant differences test. The relationship between two
methods of segmentation was plotted and described with the Pearson correlation
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coefficient (r). Differences in muscle volume measured between the two
segmentation methods were compared with a paired t‐test (for 18 cases). Level of
significance was set at p<0.05. All statistical tests except ICCs were performed with
Graphpad Prism Version 5.0b (La Jolla, CA).
4.2 RESULTS
Using the OsiriX software, intra‐rater (ICC=0.997, 0.991‐0.999) and inter‐
rater (ICC=0.997, 0.988‐0.999) reliability were high, based on 16 and 11 cases,
respectively. The same was found for the SliceOmatic software for intra‐rater
reliability (ICC=0.994, 0.989‐0.997) and inter‐rater reliability (ICC=0.998, 0.997‐
1.00) where 43 and 17 cases were analyzed, respectively.
Participant characteristics for each dataset are presented in Table 4.1. Figure
4.2 illustrates the relationships between measures of quadriceps muscle size and
isometric knee extension MVC strength for both datasets. The magnitude of the
relationship between muscle volume and strength (r2=0.73, p<0.05, Fig. 4.2a) was
larger than that for mid‐thigh CSA and strength (r2=0.62, p<0.05, Fig. 4.2b) for the
local participants. The relationship between mid‐thigh ACSA and whole muscle
volume was strong (r2=0.73, p<0.05). For the OAI dataset (Fig. 4.2c), the
relationship between quadriceps muscle volume and strength (r2=0.42) was lower
than for the local participants, but still significant (p<0.05). With regard to the
relationship between segmentation methods, a significant difference (p<0.0001)
was observed between measures of muscle volume for each segmentation method
(253.9±64.4 cm3 for OsiriX analysis vs. 316.8±73.3 cm3 for SliceOmatic analysis), but
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Table 4.1 Participant Characteristics.
Local Participants (n=36) OAI Participants (n=31)
Age
60.6±6.5
64.5±5.6
Height (m)
1.67±0.09
1.69±0.09
Weight (kg)
87.0±16.0
82.0±16.3
2
BMI (kg/m )
30.6±5.4
28.3±4.1
Isometric MVC (N•m)
157.7±72.7
109.6±47.0
Total WOMAC Score
38.2±19.6
14.7±12.6
MVC: maximal voluntary contraction; WOMAC: Western Ontario and McMaster
Osteoarthritis Index.
Data are presented as means±standard deviations.
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Table 4.2 Participant Characteristics by Disease Severity Subgroup.
Mild
Moderate Severe
pvalue
Age
60.8±8.5 59.1±6.2
61.8±4.5 0.59
Height (m)
1.69±0.10 1.71±0.12 1.67±0.05 0.61
Weight (kg) 78.5±11.6 97.0±14.7* 85.4±16.7 0.01
BMI (kg/m2) 27.5±3.3 33.5±5.2* 30.8±5.9 0.02
Data are presented as means±SD. BMI: body mass index.
*Significantly different than mild OA after post hoc testing (p<0.05)
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Figure 4.2 Univariate linear regression models with strength as the dependent
variable. Predictor variables were whole muscle volume from the local dataset (a),
mid‐thigh anatomical cross‐sectional area from the local dataset (b) and volume
from the OAI dataset (c).
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Figure 4.3 Univariate linear regression models for the relationship between muscle
volume and strength for mild (a), moderate (b) and severe (c) knee OA.
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there was a significant correlation for muscle volume measures between
segmentation methods (r=0.97, p<0.05).
Participants in each disease subgroup were similarly matched for age, height,
weight and BMI (Table 4.2), except for participants in the moderate group who had
more body mass and larger BMI than those in the mild group. Plots of the
relationships between quadriceps volume and isometric muscle strength are shown
in Figure 4.3 for each disease subgroup. The r2 values for mild, moderate and severe
OA were 0.70, 0.78 and 0.55, respectively (p<0.05).
4.3 DISCUSSION
We observed that whole muscle volume accounts for a substantial
proportion of the variability in muscle strength in patients with knee OA, which is
much higher than previously reported for this population.22 Furthermore, we
report that the magnitude of association between quadriceps muscle size and
strength may be dependent on clinical disease severity, muscle size index and MRI
protocol. These observations extend the validity of using muscle size as an outcome
measure in interventional studies in this population and also provide preliminary
data for further investigation into whether the mechanisms of muscle weakness are
altered over the severity spectrum of knee OA. Additionally, the use of different
segmentation methods for the same patient resulted in large differences in absolute
muscle volume (253.9±64.4 cm3 for OsiriX analysis vs. 316.8±73.3 cm3 for
sliceOmatic analysis), but the same relative volume (i.e. there was a strong,
significant correlation between measures derived from each technique, r=0.97),
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suggesting that relative muscle volume can be measured reliably independent of
operator or manual segmentation technique.
Quadriceps muscle weakness in patients with knee OA compared to both
healthy controls and healthy contralateral limbs has been widely reported.4 It has
often been suggested that weakness is primarily due to muscle atrophy in response
to disuse in a painful knee joint.4 However, the direct evidence in support of a
disuse atrophy model is actually quite limited. Peterson et al. reported that patients
with severe unilateral knee OA had 12% smaller mid‐thigh quadriceps ACSA in the
affected vs. contralateral limb.22 Additionally muscle fibre composition changes
analogous to those observed in age‐associated muscle atrophy (i.e. sarcopenia), such
as fibre type group and selective type II fibre atrophy have also been observed in a
study of end‐stage knee OA patients undergoing joint replacement.9 Our results
lend support to the disuse atrophy paradigm by showing the muscle volume is a
primary predictor of the variance muscle strength. While this cross‐sectional study
is limited by its inability to document atrophy or show that atrophy is the primary
mechanism of muscle weakness, it does establish a scientific basis with which to test
the temporal aspects of the relationship between muscle size, strength and disease
severity.
Calculation of muscle volume from contiguous axial slices is the current gold
standard for in vivo measurement of muscle size, however it is a time consuming
process.13 Accordingly, a number of studies have advocated for the use of single
slice, mid‐thigh ACSA as a proxy for muscle volume, citing strong correlations
between the two parameters.7, 19 Similarly, we also found a strong association
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between mid‐thigh CSA and muscle volume (r2=0.73). However, despite the
strength of association between these size indices, single‐slice mid‐thigh ACSA did
not display as strong an association with muscle strength. A recent study by
Hudelmaier et al. reported that proximal thigh, as opposed to mid‐thigh was the
region most sensitive to change in muscle mass during an exercise intervention.13 It
is possible that the mid‐thigh size in patients with knee OA is not a strong
determinant of strength and that other regions of the thigh play a more vital role in
strength and the development of weakness, although there is little experimental
evidence to substantiate this. It is unknown whether specific regions of muscle are
susceptible to atrophy in patients with knee OA (e.g. distal quadriceps in
patellofemoral OA).12
Our observation of a strong association between muscle volume and strength
in knee OA is in contrast to that of Peterson et al. who reported that neural
activation (i.e. the ability of the central nervous system to activate the entire
population of motor units during MVC) is of greater importance than muscle size in
determining muscle strength in these patients.22 We report that muscle size
explains 73% of the variance in muscle strength in knee OA versus 27% in
Peterson’s group.
There are several possible reasons for this discrepancy. First, the issue of
using single slice ACSA as a proxy for muscle volume has been described above.
Second, we tested knee OA patients with a range of clinical disease severities,
isometric strength values and muscle volumes. Testing a severe group only, as in
the study by Peterson et al. may have resulted in clustering of size and strength
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measures, making it difficult to demonstrate covariance, even though the true
correlation may be quite high.23 Third, the magnitude of the size‐strength
relationship may be influenced by disease severity. Upon stratification of knee OA
patients into homogeneous clinical severity subgroups, we observed that the size‐
strength relationship was variable (i.e. stronger for mild/moderate OA than severe
OA).
The determinants of muscle strength may change as the disease progresses.
To our knowledge, no other study has differentiated between severities of knee OA
to determine if the mechanism of muscle weakness is altered over the natural
history of disease. It has been shown in many studies that deficits in neural
activation occur in OA.11, 14, 15 However, one study using individuals with mild OA
did not show neural activation differences compared to healthy controls.17 Deficits
in neural activation are thought to arise from an inhibitory effect of pain afferents on
motor unit excitability.14 It is possible that factors such as neural activation assume
a greater role in predicting strength as joint pain becomes more severe (i.e. in the
later stages of disease).
Other factors that could influence strength independent of muscle size in
clinically severe knee OA patients include; reduced force producing capacity of
individual fibres/cross‐sectional area (i.e. reduced specific strength), changes in
muscle fibre composition and increased antagonist co‐contraction. For example,
antagonist co‐contraction has been observed in gait analysis as a potential
compensatory mechanism to provide stability to a lax knee joint.16 It is unknown
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whether co‐contraction of the agonist hamstring muscle contributes to reduced
maximal knee extensor strength during isometric contractions.
The relatively small association between size and strength observed in the
OAI dataset is surprising, despite the segmentation of a series of slices in order to
estimate whole muscle volume. It has been observed that single slice ACSA loses its
strength of prediction as the representative slice moves more proximal/distal to the
mid‐thigh region.7 While the intention of the OAI protocol was to encompass a
section of the leg containing the mid‐thigh region, an absolute criterion measure (i.e.
10 cm proximal to the epiphyseal line) was used to landmark the most distal slice in
the MRI acquisitions. As participant height and leg length are variable, image
acquisition would have been performed at a different section of the thigh for each
patient, with more distal regions acquired in taller subjects and more proximal
regions acquired in shorter subjects. Therefore the regions acquired may not have
been representative of whole muscle volume in some subjects and thus, the size‐
strength relationship was smaller than that observed for the local participant
dataset. Additionally, measurement error has been shown to increase when the
number of slices used to estimate muscle volume decrease.20 As only a small
number of slices were used (n=15), the error associated with this volume estimate
may have been large. Based on these results, it is recommended that relative
measurements (e.g. percentage of femur length) be used to identify anatomical
landmarks if only partial thigh scans are to be used in analysis, to ensure accurate
scanning for all study participants.
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It should be noted that the quadriceps size‐strength relationship could also
have been affected by the different methods for measuring isometric strength. In
the OAI participants, the joint angle used for isometric strength measurement was
different than that used in the local participants. In the OAI participants, the joint
angle selected was 60° from full knee‐extension, while in the local participants a
standard joint angle of 90° (measured as the angle between the thigh and lower‐
limb) was selected. It is possible that some OAI participants with reduced range of
motion were not able to achieve the same degree of knee extension and thus the
measured joint angle could be variable for these participants. Consequently,
isometric strength testing could have been performed at different muscle lengths,
which would have an effect on the length‐tension relationship and the resulting
strength outcomes.27 The size‐strength relationship may also be affected by the
type of muscle contraction used to represent strength. Blazevich et al. reported that
muscle volume was the most robust predictor of isometric and slow (30°/s),
concentric isokinetic contractions, but the product of physiological cross‐sectional
area and fascicle length explained a greater proportion of the variance for fast
(300°/s) concentric isokinetic contractions.5 The effect of variation in joint angles
and type of muscle contraction used to represent muscle strength on the size‐
strength relationship requires further investigation.
Despite evidence that automated segmentation methods accurately predict
whole quadriceps muscle volume,20 the majority of studies evaluating size‐strength
relationships use manual segmentation methods. Few studies have evaluated the
reliability of manual segmentation methods even though they may be operator,
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software and image sequence dependent. Our study showed that segmentation
methods using different software programs have excellent intra‐ and inter‐rater
reliability. Furthermore, there was an excellent correlation (r=0.97) between
absolute muscle volume measures calculated using the two different techniques,
although absolute agreement between the two techniques was poor (i.e. significant
difference observed between the two absolute measures). One potential cause of
the poor agreement between techniques was the differences in segmentation
techniques in the OsiriX software compared to SliceOmatic (i.e. region growing from
a defined seed‐point based on pixel intensity, automatic generation of missing ROIs
compared to watershed technique). This could have eliminated operator error by
automatically excluding non‐muscular tissue above/below certain intensity
thresholds so as not to include non‐muscular tissue in the analysis. It was evident
that a greater proportion of non‐muscular tissue was eliminated using the first
method, as absolute muscle volume estimates were consistently smaller. Despite
poor absolute agreement our results suggest that relative measures of muscle
volume can be acquired reliably, regardless of segmentation method or operator.
In conclusion, the results of our study indicate that muscle volume is strongly
associated with isometric muscle strength in patients with knee OA, although this
relationship may change as clinical disease severity changes or if proxy measures
are used to estimate muscle volume. These results provide support for the use of
muscle volume as an outcome measure in interventional trials designed to improve
strength and also provide a preliminary investigation into the mechanisms of
muscle weakness across a clinical spectrum of knee OA.
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CHAPTER 5
QUADRICEPS MUSCLE MASS AND VOLUNTARY ACTIVATION ACROSS A
CLINICAL SPECTRUM OF KNEE OSTEOARTHRITIS

5.0 INTRODUCTION
Quadriceps muscle weakness in knee osteoarthritis (OA) has been widely
reported,6 is associated with pain and disability,24, 30 is an important predictor of
disability following joint replacement26 and may be linked with disease incidence
and progression.21, 34, 38 Accordingly, conservative, non‐surgical management of OA
includes interventions designed specifically to attenuate reductions in muscle
strength.42 However, meta‐analysis of clinical trials shows only small improvements
for pain and function (i.e. comparable to non‐steroidal anti‐inflammatories)
following quadriceps strengthening exercise12 and trials assessing the efficacy of
exercise using quadriceps strength as a primary outcome measure are equivocal.2, 22
An incomplete understanding of the mechanisms of quadriceps weakness could
explain the negative outcomes for some clinical trials involving quadriceps
strengthening exercise.
A widely accepted model for muscle weakness purports that pain from OA
leads to a perpetuating cycle of disuse, followed by muscle atrophy. However, the
evidence that this is actually occurring and that atrophy is a significant contributor
to weakness and subsequent disability is limited. Peterson et al. reported
reductions in muscle mass of 12% between a thigh with severe radiographic knee
OA and a contralateral control thigh, although muscle mass was a weak predictor of
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strength.31 In another study, quadriceps cross‐sectional area had only a small
positive correlation with muscle strength in those with moderate radiographic OA.14
Few studies at the muscle fibre level are able to substantiate the disuse model. Fink
et al. performed muscle biopsy of OA patients at the time of arthroplasty and
reported predominantly type II atrophy with some type I atrophy and fibre type
grouping in the vastus lateralis muscle.11 These observations are consistent with
disuse but without a control group, are difficult to distinguish from changes in
muscle fiber composition associated with normal aging.
With limited evidence in favour of a simple disuse model, some attention has
shifted to other potential mechanisms, principally a reduction in voluntary
activation (VA) of the quadriceps. The term “arthrogenous muscle inhibition” was
coined by Hurley and Newham to describe the apparent inhibition of high threshold
motor units by pain afferents, during maximal voluntary contractions (MVC),
leading to a reduction in VA.19 There is evidence that VA is reduced in OA up to 20%
compared to a non‐diseased limb or healthy control.16 However, there is
considerable variability in the magnitude of VA deficits between studies, including
one recent study in patients with mild OA showing no reduction in VA compared to
healthy controls.23
It is possible that the degree of disease severity predicts the magnitude of
muscle atrophy or VA deficit, although this has yet to be investigated. In many
studies assessing quadriceps muscle function in knee OA, disease is defined
dichotomously (i.e. presence or absence). This does not allow for analysis of how
quadriceps muscle function progresses across a disease spectrum. Consequently, the
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optimal type and time for intervention remains unknown. Furthermore, disease
cohorts are often stratified based on radiographic disease severity, which is known
to have a tenuous relationship with clinical severity and thus OA subgroups may be
clinically heterogeneous in composition.3 Therefore, the purpose of this study was
to evaluate strength, muscle volume and VA across a clinical spectrum of knee OA.
5.1 METHODS
5.1.1 Patient characteristics and stratification for disease severity
Thirty‐six community dwelling men and women participated in the study.
Participants were included if they had persistent knee pain that required referral to
an orthopedic surgeon and/or X‐ray findings consistent with knee OA in at least one
compartment (e.g. presence of osteophytes, apparent joint space narrowing,
subchondral sclerosis and areas of cyst formations) confirmed by an experienced
musculoskeletal radiologist or orthopedic surgeon. Participants also met the
American College of Rheumatology definition of knee OA.1 Exclusion criteria
included musculoskeletal, neurological or rheumatological impairment of the lower
limbs other than knee OA, prior high tibial osteotomy, unicondylar or total knee
arthroplasty or cardiopulmonary impairment that precluded performing vigorous
muscle contractions. If a patient had bilateral knee OA, the limb with the most
severe symptoms (as reported by the patient), was selected as the test limb. Ethical
approval for the study was obtained from the local institutional ethics review board
and written consent was obtained from each participant prior to study
commencement. Measurement of quadriceps muscle strength, VA and muscle
volume was undertaken as part of a comprehensive assessment of neuromuscular
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function that also included procedures for measurement of muscle power and
muscle contractile properties. The entire test protocol was completed in a single
visit to the Neuromuscular Assessment Laboratory. The order of all testing
procedure was randomized and a minimum of 10 minutes rest was allotted between
testing sessions, in order to minimize fatigue and learning effects.
The Western Ontario and McMaster Osteoarthritis Index (WOMAC) was used
to stratify subjects into study groups based on clinical disease severity. WOMAC is a
validated questionnaire that is widely used to quantify clinical severity of knee OA.5
The WOMAC Likert version 3.0 has 24 items and is divided into pain, stiffness and
function domains. Each item has 5 response options (none, mild, moderate, severe,
extreme) corresponding to scores 0‐4, with higher scores indicating increasing
severity. WOMAC scores were used as the independent variable in this study
whereby total score (24 items, total score 0‐96) was used stratify study participants
into tertiles, with the lowest, middle and highest groups representing mild,
moderate and severe clinical knee OA, respectively.
5.1.2 Measurement of isometric muscle strength and voluntary activation
For both strength and VA measurements, participants were seated upright in
multi‐joint dynamometer (Biodex System 3, Shirley, NY), with knee and hip angles of
90° and 100° respectively. The centre of rotation of the knee was aligned with the
axis of rotation of the dynamometer’s lever arm. The force transducer was
positioned with its bottom edge two fingerbreadths proximal to the medial
malleolus of the test leg and fixed with a Velcro strap. A seat‐belt strap was
positioned across the lap in order to avoid unwanted movement. Furthermore,
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during all contractions, the participants were instructed to fold their arms across
the chest and to avoid hip flexion, so that the contribution of synergist muscles to
torque could be attenuated.
The highest torque output achieved during repeated (3‐5 repetitions)
isometric quadriceps maximal voluntary contractions (MVCs) was used to represent
muscle strength. Torque was normalized to body mass (N•m/kg) in order to control
for sex and body mass differences between participants. The test protocol
commenced with a series of submaximal isometric contractions (approximately 50‐
75% of maximal intensity) for the purposes of warm‐up and familiarization.
Participants then performed repeated, brief (~5 s) isometric MVCs of the quadriceps
(3‐5 repetitions), each separated by a minimum of 90 s of rest. Maximal contraction
intensity was attained when two consecutive MVCs differed by less than 5%.
The interpolated twitch technique was used to measure VA. The premise of
the technique is that additional twitch torque resulting from a supramaximal
stimulus superimposed on a MVC is indicative of reduced central drive to the muscle
resulting in incomplete activation. Normalizing the superimposed twitch to a
resting, potentiated control twitch provides an index of VA:

VA = [1 – (Superimposed Twitch /Potentiated Resting Twitch)] x 100%4

equ. 1

The intramuscular fibres of the femoral nerve supplying the quadriceps were
stimulated supramaximally with a constant current stimulator (Digitimer DS7AH,
Digitimer Ltd., Hertfordshire, UK). Aluminum foil electrodes, wrapped in paper
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towel, soaked in water and conducting gel were cut into 6 cm strips (lengthwise)
and placed over the belly of the quadriceps. Before application of the electrodes,
patients were asked to perform submaximal isometric knee extension contractions,
so that the bellies of the quadriceps could be visualized and palpated, to avoid
erroneous electrode placement over antagonist muscle fibres. Electrodes were then
cut widthwise so that no conducting material was placed over antagonist muscle
fibres. The cathode was placed with its proximal edge at a point just distal to the
inguinal crease and the distal edge of the anode was placed three fingerbreadths
proximal to the base of the patella. In order to improve sensitivity of the technique
for detecting superimposed twitches, doublets were used to stimulate the
quadriceps at rest and MVC (pulse width=100 μs, interpulse interval=10 μs, 400
V).37 To ensure that the stimulus was supramaximal prior to study onset, a series of
incremental stimuli of increasing intensity were delivered to the resting muscle.
Once the torque output reached a plateau, the stimulus was deemed maximal (this
usually occurred at an intensity of 300‐600 mA). The stimulus intensity was then
increased an additional ~10% to achieve supramaximality. Patients were then
instructed to perform an MVC in an identical fashion to the description above. When
a plateau in the torque tracing was perceived during MVC (~3s into the contraction),
the stimulator was triggered manually by the study examiner. The MVC lasted for
~5s and was followed ~3 s later by the resting stimulus. This procedure was
repeated 3‐4 times for each subject with a minimum of 90 s rest between trials. VA
was calculated as the median for all acceptable trials.
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For both MVC and VA testing, torque was sampled at 100 Hz, AD converted
with a 12‐bit converter (CED micro1401 mk II, Cambridge Electronic Design
Limited, Cambridge, UK) and displayed in real‐time on an online digital system using
commercially available software (Spike2 ver. 5, Cambridge Electronic Design). Loud
verbal encouragement and visual feedback using the real‐time digital torque was
used during all contractions to ensure maximal intensity.
5.1.3 Magnetic resonance imaging methods and volume estimation
MRI scans of the thigh were acquired using a 3.0T MR system (GE Discovery
MR750, GE Healthcare, Waukesha, Wisc.) with an 8‐coil torso phased array. The
patient was positioned supine in the scanner bore. A 3‐plane localizing scan and
calibration scan were performed to ensure the anatomy of interest was contained in
the field‐of‐view (FOV). Three‐dimensional axial images were acquired from
proximal (femoral head) to distal (femoral condyles) with a proton density weighted
multiecho‐spoiled gradient echo (SPGR) imaging sequence (FOV: 42‐46x21‐23 cm,
slice thickness: 4 mm, matrix: 320x160x120, TR: 7.4 ms, echoes: 6, TE, 1.4, 2.1, 2.9,
3.6, 4.4, 5.1 ms, flip angle 5°, bandwidth: ± 142.86 kHz). An investigational version
of the IDEAL (iterative decomposition of water and fat with echo asymmetry and
least squares estimation) multipoint water‐fat separation method that is T1
independent, T2* corrected and employs accurate spectral modeling of fat, was used
to reconstruct both water‐only and fat‐only images from the multiecho SPGR source
images.33, 41 Fat‐water separation also ensured that non‐muscle tissue (in particular
fat) was not included in analysis of the thigh images. Image analysis was performed
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on the water only images produced by the IDEAL reconstruction for assessment of
muscle volume.
A combination of manual and semi‐automated techniques using open‐source
OsiriX image processing software (version 3.7, Geneva, Switzerland) was used to
analyze images and calculate muscle volume. Analysis began proximally from the
first slice not containing the gluteal muscle to the last distal slice containing the
rectus femoris, as this region is thought to represent maximal thigh muscle mass40
and because it is difficult to differentiate between thigh muscles at the most
proximal and distal slices.9 Quadriceps muscle volume was calculated from the
water‐only images by manually outlining the most proximal and distal slices with
the brush tool to create regions of interest (ROI). This process was repeated for
every tenth slice in‐between and missing ROIs were generated automatically. Once
the quadriceps had been roughly outlined, all pixel values outside the ROIs were set
to zero. Subsequently, a 3D threshold‐growing tool was used to grow ROIs for the
quadriceps muscle tissue only from a defined seedpoint within the muscle. This was
done to ensure exclusion of non‐muscular tissue in the septal spaces. Any errors
produced by the automatic tool were corrected manually. The software
automatically calculated volume for the series of ROIs. The reliability of this method
defined by the intraclass correlation coefficient (ICC; 2,1) and 95% confidence
intervals was high (intra‐rater: ICC=0.997, 0.991‐0.999 and inter‐rater: ICC=0.997,
0.988‐0.999 based on 16 and 11 cases, respectively). Axial single‐slices taken from
the mid‐thigh region for representative subjects from the mild and severe groups
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are presented in Figure 5.1. Quadriceps muscle volume was normalized to number
of slices used in the analysis to control for differences in thigh length.
5.1.4 Statistics
One‐way ANOVA with post‐hoc Tukey’s honestly significant differences
testing was used to compare quadriceps muscular strength and volume across the
different severity groups. A Kruskal‐Wallis with post‐hoc Dunn’s test was used to
compare differences in VA. A stepwise multiple regression model was used to
determine the relative contributions of muscle volume and VA to the variance in
isometric strength. Univariate linear regression models were used to determine the
relationships between VA and pain and function scores on the WOMAC. Differences
in absolute torque values between isometric strength testing and the interpolated
twitch technique were compared with a paired t‐test. Level of significance was set at
p<0.05. All normally distributed data are described with mean±standard deviation
(SD). VA is non‐Gaussian and central tendency is described with median and 95%
confidence intervals. All statistical analyses were performed with Graphpad Prism
Version 5.0b (La Jolla, CA).
5.2 RESULTS
Participant characteristics, including normalized strength, muscle volume
and VA measures for each disease subgroup are presented in Table 5.1. Participants
in each group were relatively similar for age, height and body size, although those in
the moderate group were slightly heavier and had greater body mass index than
those in the mild group (p<0.05). Sex differences were noted between groups with
the mild group having double the number of men and the severe group having
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Table 5.1 Participant characteristics (n = 36).
Mild
Moderate
Severe
pvalue
Sex (Male/Female)
8/4
5/7
4/8
Age
0.59
60.8±8.5
59.1±6.2
61.8±4.5
Height (m)
0.61
1.69±0.10
1.71±0.12
1.67±0.05
Weight (kg)
<0.05
78.5±11.6
97.0±14.7*
85.4±16.7
BMI (kg/m2)
<0.05
27.5±3.3
33.5±5.2*
30.8±5.9
WOMAC total score
<0.05
16.6±8.1
37.5±6.5*
60.5±7.4*†
†
<0.05
WOMAC pain score
4.5±2.4
6.9±2.2
11.9±1.9*
<0.05
Strength (N•m/kg)
2.30±0.77
1.78±0.74
1.29±0.51*
Muscle volume (cm3/# slices) 23.68±6.84
<0.05
22.47±6.30
17.7±3.95*
% VA
95.3
95.7
89.9
0.06
(91.8‐98.8)
(93.7‐97.6)
(85.3‐94.4)
Data are presented as means±SD, except for %VA, which has 95% confidence
intervals in parentheses). BMI: body mass index; %VA: percent voluntary activation.
*Significantly different from mild OA after post hoc testing (p<0.05).
†Significantly different from moderate OA after post hoc testing (p<0.05).
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Figure 5.1 Axial view of the mid‐region of the right thigh for representative male
subjects from the mild (a) and severe (b) disease subgroups. The four bellies of the
quadriceps are labeled VM (vastus intermedius), RF (rectus femoris), VI (vastus
intermedius) and VL (vastus lateralis).
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double the number of women, however an attempt was made to control for these
differences by normalizing muscle parameters. Significant differences were
observed for WOMAC total and pain sub‐scale scores (p<0.05). Post hoc testing
revealed that each group differed significantly for total WOMAC score, while the
severe group was significantly different from both mild and moderate groups for
pain sub‐scale score. A significant difference was observed for normalized strength
(p<0.05). With post hoc testing, the difference between mild and severe groups
remained significant with those in the severe group having ~44% lower strength.
Similarly, normalized muscle volume was significantly reduced in the severe
compared to mild group (~25% reduction, p<0.05). No significant difference across
groups for VA was evident (p>0.05).
A non‐significant ~5‐6% difference in VA was observed in the severe
compared to mild and moderate groups. Five subjects in the mild group, and 4
subjects in the moderate group achieved 100% activation in at least one trial
compared to only two subjects in the severe group. Intersubject variability in VA
was similar across clinical severity of OA, although slightly higher in the severe
group. Coefficients of variation were 5.8, 3.2 and 8.0% in the mild, moderate and
severe groups, respectively.
Participants were able to produce ~10 N•m more torque during simple
isometric strength testing than during testing with the interpolated twitch
technique (MVC during isometric strength testing = 157±72 N•m vs. MVC during
interpolated twitch = 147±72 N•m, p<0.05).
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Figure 5.2 Linear regression models depicting the relationship between % voluntary
activation (VA, x‐axis) and self‐reported pain (a) and function (b).
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From the multiple regression analysis, the combination of muscle volume
and VA predicted 75% of the variance in isometric strength (adjusted R2=0.75,
p<0.05). When VA was removed from the analysis, muscle volume alone explained
72% of the variance in isometric strength (β = 0.85). Thus, VA only accounted for an
additional 3% of the variance in strength (β = 0.20). Individual univariate linear
regression models with VA as the dependent variable are illustrated in Figure 5.2. A
small, but significant association was observed between VA and self‐reported pain
on the WOMAC questionnaire (r2=0.18, p<0.05, Fig. 5.2a), but no association was
observed between VA and self‐reported function (r2=0.09, p>0.05, Fig. 5.2b).
5.3 DISCUSSION
The results of this study suggest that quadriceps muscle volume is a primary
determinant of knee extensor strength and those with clinically severe knee OA
have reduced muscle mass relative to those with mild disease. Furthermore, VA
deficits reported in previous studies may have been overestimated. With ample
practice and motivation, no significant differences in VA were observed across a
clinical spectrum of knee OA. The small VA deficits in some subjects observed in this
study may be related to knee pain, however the clinical significance of these deficits
is questionable. These results have implications for the rehabilitation of quadriceps
muscle weakness in knee OA.
Knee OA as a model of quadriceps disuse atrophy has been suggested
previously.18 The results of this study highlight the strong relationship between
muscle mass and strength. However due to the cross‐sectional design, these results
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do not provide direct evidence for disuse atrophy per se because it is difficult to
determine the temporality of the relationship between changes in muscle mass and
clinical disease severity. Indeed, reduced muscle mass may predispose a patient to
more severe knee OA. Reductions in muscle strength have been shown to predict
both radiographic21, 39 and symptomatic disease incidence35 in large population
studies. This has also been substantiated in an animal model of botulinum toxin
induced quadriceps muscle weakness.34 However, a similar association between
strength and disease progression has not been reported.8 Studies incorporating a
measure of muscle mass have been conflicting, with one reporting a protective effect
for increased muscle mass on radiographic disease incidence21 and one reporting
that women with muscle weakness who developed incident radiographic knee OA
had increased muscle mass compared to those who did not.39 The relationship
between strength and disease incidence and progression becomes more complex
when one considers the recent study by Sharma et al. reporting a negative effect of
quadriceps strength in malaligned and lax knees.36
Regardless of the temporality of the relationship between muscle mass and
disease severity and the mechanism of atrophy, this study illustrates the importance
of muscle mass to quadriceps strength, a finding that has not been supported by
previous research. From the multiple regression analysis, it was clear that muscle
volume alone accounted for large proportion of the variance in isometric strength
(73%), while VA explained only an additional 4%. Conversely, Peterson et al.
reported that VA was more predictive of variance in strength than quadriceps cross‐
sectional area 31. Also, Gur and Cakin reported only a moderate relationship
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between concentric strength and mid‐thigh quadriceps cross‐sectional area,
measured by computed‐tomography.14 A strength of our study was the use of novel
imaging and segmentation techniques to quantify muscle volume to eliminate the
possibility of confusing bright water signal for fat. Any such misidentification would
introduce error into the measurements of both compartments since a misidentified
pixel would be removed from the volume of the correct compartment and added to
the volume of the incorrect compartment. Furthermore, we segmented a large
volume of the quadriceps as opposed to estimating volume using a single mid‐thigh
slice of the quadriceps, which has been shown to have error of 10% or greater
depending on the slice used.28 The observation that muscle mass is the greatest
predictor of strength in knee OA is consistent with the aging literature.10 Thus,
preservation of muscle mass should be an important outcome of intervention (see
below).
Contrary to previous studies in this area, we did not observe a significant
difference in VA across a spectrum of disease severity. Our results can likely be
attributed to a combination of factors related to study design and to technical issues
related to the interpolated twitch technique. VA values observed in this study are
similar to those reported previously in the quadriceps of healthy participants.29, 32
Participants in this study had ample warm‐up and practice prior to undergoing
testing with the interpolated twitch technique. Furthermore, participants also
completed other tests within a single session for measurement of muscle power and
muscle contractile properties involving a large number of maximal and submaximal
contractions (data not reported). Therefore, participants were well familiarized
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prior to VA assessment. From a technical perspective, many studies of activation in
knee OA have used the central activation ratio as an index of VA.27, 31 This technique
employs high frequency trains to stimulate the quadriceps during MVC, which may
cause pain and subsequent inhibition of motor units leading to apparent decreases
in activation. In other studies, VA has been calculated by normalizing the
superimposed twitch to an unpotentiated resting twitch,15, 20 which would cause an
overestimation of VA deficit, since the superimposed twitch itself is potentiated by
the MVC. We controlled for many methodological errors that may occur when using
the interpolated twitch technique including 1) the use of a superimposed doublet for
improved sensitivity, 2) verification of supramaximality of the stimulus and 3)
normalization the superimposed twitch to a potentiated control twitch.37
It should be noted that one subject in the mild group had a median VA of
79.6%, the second lowest score in the study. This score was also greater than two
standard deviations below mean VA for the mild group and could be considered an
outlier. Removing this subject from the analysis led to a significant difference in VA
between mild and severe knee OA (p<0.05). It could be that VA is dependent to a
certain extent on disease severity. Pain afferent inhibition of high threshold motor
units during high intensity contractions (i.e. “arthrogenous muscle inhibition”) has
been postulated as the mechanism of reduced VA in knee OA.19 Correspondingly, we
showed a small but significant relationship between self‐reported pain and VA (Fig
5.3a). However, self‐reported pain (Table 5.1) was significantly greater in the
severe group, with only a small, non‐significant reduction in VA.
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The relevance of a 5‐6% deficit in VA in the severe group compared to mild
or moderate knee OA is questionable. First, no relationship was observed between
VA and self‐reported function in this study (Fig. 5.3b). Second, we have recently
reported on the validity of the interpolated twitch technique and have questioned
its utility as an absolute measure of neural activation due to lack of responsiveness
of the motor neuron pool to external stimulation because of the hyperpolarizing
effects of voluntary activity during the MVC.7 Third, small deficits in VA during
maximal isometric contractions intuitively have little functional relevance as the
activities of daily living are usually performed dynamically and at submaximal
contractile intensities. There is indirect evidence to suggest that submaximal
contractions are impaired in patients with knee OA,17 however no study has
measured intrinsic muscle and motor unit properties at lower intensities in this
population.
There are several limitations to this study. The limitation of the cross‐
sectional design in establishing temporality of association has been described above.
A second limitation is the use of a continuous measure of disease severity to stratify
patients into tertiles. There is currently no optimal measurement tool that can be
used to stratify knee OA patients based on severity.13 WOMAC was chosen in this
study over commonly used radiographic scoring of knee OA (e.g. Kellgren‐Lawrence
scale), due to questionable relationship between radiographic and clinical severity.3
While WOMAC is a widely accepted research tool, the use of a continuous measure
implies arbitrary cutoff points, which may have produced variability within the
study groups. Another limitation in interpreting the results arises from the sex
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differences between study subgroups. While participants were relatively similar for
age and body size (Table 5.1), the severe group had a higher proportion of women.
We attempted to control for this discrepancy by normalizing strength to body mass
and muscle volume to number of slices (i.e. a measure of thigh length), however it is
unknown if the magnitude of the deficits reported in the severe category would be
the same if either men or women were assessed in isolation. We did not possess the
necessary study power to analyze subgroups based on sex.
In summary, this study found that quadriceps muscle volume was the
primary determinant of knee extensor strength across a clinical spectrum of knee
OA. Reduced muscle mass in severe knee OA should be targeted with interventions
specifically designed to preserve and increase muscle mass. For example, it is well
established that the benefits of short‐term resistance training exercise (e.g. 1‐2
weeks in duration) are primarily neural, (i.e. improvements in VA).25 Thus short
term resistance training programs may not appropriately target the mechanism of
muscle weakness in patients with knee OA. Furthermore, the clinical significance of
the small non‐significant deficits in VA observed in this study is questionable.
Therefore, we propose that future studies investigate the efficacy of longer duration,
hypertrophy‐inducing resistance training programs on improving strength, pain and
functional outcomes.
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CHAPTER 6
QUADRICEPS CONTRACTILE AND MOTOR UNIT PROPERTIES IN KNEE
OSTEOARTHRITIS

6.0 INTRODUCTION
Quadriceps muscle weakness is commonly associated with knee
osteoarthritis (OA). The relationship between weakness and disability has been well
documented22, 23 and quadriceps weakness may be a risk factor for disease
incidence and progression.2, 28 An understanding of the mechanisms and natural
history of quadriceps weakness in knee OA is critical in order to optimize the type
and timing of both rehabilitative and surgical interventions. Furthermore,
knowledge of the how the neuromuscular system is affected in knee OA may provide
information about disease prognosis and the ability of the quadriceps to recover
after interventions such as joint replacement.
Weakness in knee OA is usually attributed to a progressive pattern of disuse
from knee pain, resulting in muscle atrophy and associated loss of strength.7
Characteristic deficits related to disuse including reduced muscle size and increased
neural inhibition12 have been reported in cross‐sectional studies of knee OA.16, 18, 24
Experimentally controlled studies of disuse employing immobilization, bed rest or
microgravity have reported alterations in single fibre protein expression (i.e.
increased expression of myosin heavy chain (MHC) IIa and IIx proteins), frequently
leading to a speeding of whole muscle contractile properties.12 It is possible that
knee OA constitutes a clinically applicable model of chronic disuse, however no
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study to date has measured quadriceps muscle contractile properties in this patient
population.
There is also evidence to suggest that the individual motor units (MUs)
supplying the quadriceps may be affected by knee OA. Neural inhibition,
presumably due to pain preventing maximal MU recruitment and/or rate coding
during maximal isometric contractions has been widely reported.17 Measures of
neural inhibition during maximal contractions do not provide information about
individual MUs. Studies of individual MU behaviour at low intensity contractions
may be more clinically relevant as most activities of daily living require low‐to‐
moderate intensity quadriceps contractions. There is also evidence of MU
remodeling from one study of patients with radiographically severe knee OA.20
However, this observation requires confirmation as radiographic definition of
disease severity may not be appropriate when investigating neuromuscular
outcomes.23 In order to further understand the mechanisms of muscle weakness in
knee OA, the purpose of this study was to investigate whether in vivo contractile and
MU properties (e.g. motor unit potential size and firing rates) are altered in knee OA.
6.1 METHODS
6.1.1 Study participants
6.1.1.1 Study participants for measurement of contractile properties
Thirty‐nine community dwelling men and women underwent testing of
quadriceps evoked contractile properties. Participants were included if they had
persistent knee pain that required referral to an orthopedic surgeon and/or X‐ray
findings consistent with knee OA in at least one compartment (e.g. presence of
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osteophytes, apparent joint space narrowing, subchondral sclerosis and areas of
cyst formations) confirmed by an experienced musculoskeletal radiologist or
orthopedic surgeon. Participants also met the American College of Rheumatology
definition of knee OA.1 Exclusion criteria included: prior high tibial osteotomy,
unicondylar or total knee arthroplasty, musculoskeletal, neurological or
rheumatological impairment of the lower limbs other than knee OA, or
cardiopulmonary impairment that precluded the performance of vigorous muscle
contractions. If a patient had bilateral knee OA, the limb with the more severe
symptoms (as reported by the patient), was selected as the test limb. Ethical
approval for the study was obtained from the local institutional ethics review board
and written consent was obtained from each participant prior to study
commencement.
Quadriceps muscle contractile properties were compared across a clinical
spectrum of knee OA. In order to facilitate comparison, participants were stratified
into tertiles of disease severity based on their responses to the Western Ontario and
McMaster Osteoarthritis Index (WOMAC). WOMAC is a validated, widely used tool
used to quantify clinical severity in knee OA patients.5 The lowest, middle and
highest tertiles were designated mild, moderate and severe knee OA respectively.
6.1.1.2 Study participants for measurement of vastus medialis motor unit
properties
Measurement of vastus medialis MU properties was undertaken in a separate
study sample. Eight participants with knee OA and eight healthy, age‐matched
control subjects participated in this part of the study. Participant recruitment
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strategy and inclusion/exclusion criteria were identical to that described above for
the OA participants. Control subjects were recruited from the local university
community and had no self‐reported history of knee pain.
6.1.2 Measurement of isometric muscle strength
Isometric MVCs were performed in both parts of the study in order to
measure maximal strength and to use as a reference for normalization of
submaximal contractions and stimulus intensity levels. Participants were seated
upright in a multi‐joint dynamometer (Biodex System 3, Shirley, NY), with knee and
hip angles of 90° and 100° respectively. The centre of rotation of the knee was
aligned with the axis of rotation of the dynamometer’s lever arm. The force
transducer was positioned with its bottom edge two fingerbreadths proximal to the
medial malleolus of the test leg and fixed with a Velcro strap. A seat‐belt strap was
positioned across the lap in order to avoid unwanted movement. The test protocol
commenced with a series of submaximal isometric contractions (approximately 50‐
75% of maximal intensity) for the purposes of warm‐up and familiarization.
Participants then performed repeated, brief (~5 s) isometric MVCs of the quadriceps
(3‐5 repetitions), each separated by a minimum of 90 s of rest. Maximal contraction
intensity was attained when two consecutive MVCs differed by less than 5%. Visual
feedback in the form of the real‐time torque tracing and verbal encouragement were
provided as motivation. Torque was sampled at 100 Hz, AD converted with a 12‐bit
converter (CED micro1401 mk II, Cambridge Electronic Design Limited, Cambridge,
UK) and displayed in real‐time on an online digital system using commercially
available software (Spike2 ver. 5, Cambridge Electronic Design). Torque was
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normalized to body mass to control for sex and body size differences between
participants. The same force measurement procedure was used during the
submaximal contractions performed during the recording of MU properties (see
below).
6.1.3 Electrically evoked contractile properties
The intramuscular branches of the femoral nerve were stimulated with a
constant current stimulator (Digitimer DS7AH, Digitimer Ltd., Hertfordshire, UK) to
evoke quadriceps muscle twitches and to measure the torque‐frequency
relationship. Aluminum foil electrodes soaked in water and conducting gel were cut
into 6 cm wide strips and placed over the belly of the quadriceps. Before application
of the electrodes, patients were asked to perform submaximal isometric knee
extension contractions, so that the bellies of the quadriceps could be visualized and
palpated in an attempt to avoid erroneous electrode placement over antagonist
muscle fibres. Electrodes were then cut lengthwise so that no conducting material
was placed over antagonist muscle fibres. The cathode was placed with its proximal
edge at a point just distal to the inguinal crease and the anode was placed three
fingerbreadths proximal to the base of the patella.
Resting twitches were elicited using single pulses of 100 μs duration (1 Hz,
400 V). Stimulus intensity was increased incrementally until a plateau in twitch
torque was observed. Stimulus intensity was then increased an additional 10% in
order to ensure that the stimulus was maximal. Three maximal twitches were
recorded separated by 30 s rest, in order to avoid potentiation effects. Twitch
parameters assessed during offline analysis were the mean of peak twitch tension
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(PT), time to peak tension (TPT) and half‐relaxation time (HRT), for the three
twitches.
Resting torque‐frequency characteristics were measured using trains of 500
μs pulses delivered at 1, 5, 8, 10, 12, 15, 17, 20, 25, 30, 40, 50, 75 and 100 Hz. The
stimulus intensity selected was that required to elicit a contraction equivalent to
20% MVC torque, using the 100 Hz train. Trains were separated by 10s and were
delivered in a random order to control for potentiation effects. Torque values were
normalized to torque at 100 Hz and the torque‐frequency curve for each subject was
modeled.
6.1.4 Motor unit properties
Decomposition‐enhanced spike‐triggered averaging (DE‐STA) was used to
extract information about individual MUs from both the intramuscular concentric
needle signal and the surface electromyography (EMG) interference pattern. The
DE‐STA method and algorithms have been described in detail previously.14, 31
Briefly, both intramuscular concentric needle and surface EMG signals are acquired
simultaneously during a sustained isometric contraction. A series of algorithms
decomposes the concentric needle detected EMG signal into its constituent motor
unit potential (MUP) trains using information related to both MU shape and firing
times. The firing times of the detected and classified needle MUPs (N‐MUP) from
each train are then used as triggers for locating time‐locked 100 ms epochs in the
surface signal. These surface signal epochs are then averaged to extract a surface
MUP (S‐MUP) template for a particular MUP train. The concentric N‐MUP template
is based on a median filtered average of 51 isolated MUPs.

129

Needle and surface EMG signals were acquired from the vastus medialis
muscle using custom DE‐STA software on the Neuroscan Comperio system
(Neuroscan Medical Systems, El Paso, TX). N‐MUPs were detected with a
commercially available disposable concentric needle electrode (model no. N53153;
Teca Corp., Hawthorne, NY). Self‐adhesive silver/silver chloride electrodes were cut
into 1 cm x 3 cm strips and applied over the area of interest, after abrasion of the
skin with isopropyl alcohol pads. The active electrode was applied to the belly of
the vastus medialis (3 fingerbreadths superiolateral to the base of the patella),
approximately over the motor point. The reference and ground electrodes were
applied to the patella and the lateral thigh, respectively. Surgical tape was used to
reinforce the electrode position to limit movement during the study. The needle and
surface signals were amplified and filtered with a bandpass of 10 Hz to 10 kHz and 5
Hz to 5kHz, respectively.
Subjects were positioned in the dynamometer and completed the protocol
for determination of isometric MVC as described above. Subsequently, the needle
was inserted into the muscle belly ~1 cm distal to the active surface electrode at a
depth of ~0.5‐1cm and held in place manually. Participants were asked to contract
minimally while the needle position was adjusted to minimize the rise times of the
N‐MUPs from the first 2‐3 recruited MUs. Participants performed repeated
contractions at two intensity levels; 10% and 20% MVC. Two levels were selected in
order to sample MUs of increasing size that are recruited at progressively higher
contraction intensities. These particular intensities were selected because
participants had difficulty maintaining higher intensity levels for the required 30 s
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and because the complex interference pattern generated at higher intensities is
difficult to accurately decompose and may under represent smaller MUs.9 A target
line was placed across the real‐time torque tracing and auditory feedback of the
firing pattern was used to ensure maintenance of a steady contraction. Each
contraction lasted 30 s, which was the time necessary to allow for an adequate
number of averages to adequately extract the S‐MUPs. Successive contractions for a
particular intensity level were separated by at least 30 s and approximately 2 min.
rest was allotted between intensity levels. The order of the contraction intensities
was randomized for each participant. Three to nine contractions were required for
each intensity level in order to acquire a sample of at least 20 distinct N‐MUPs and
S‐MUPs for analysis. For each contraction, the needle position and depth were
altered to increase the possibility of detecting different N‐MUP trains. A new needle
insertion site was also used between intensities to decrease the likelihood of
sampling the same MU repeatedly.
Offline analysis of each N‐MUP train and S‐MUP was performed to determine
acceptability. Rejection criteria for an N‐MUP train or S‐MUP included a template
with less than 51 individual contributions, a non‐gaussian MU interdischarge
interval (IDI) histogram, a coefficient of variation greater than 0.3 for the IDI and a
non‐physiological or inconsistent firing rate. Subsequently, all N‐MUP trains and
their respective N‐MUPs and S‐MUPS were visualized and markers for onset,
negative‐peak, positive‐peak and endpoint were readjusted manually when
necessary (see Appendix D for decomposition results from a typical 30‐s contraction
from the vastus medialis of a representative control participant). Reliability of the
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analysis has been previously established in healthy and diseased populations8. The
ﬁring pattern of each MUP was characterized by a histogram and estimation of the
mean interdischarge interval (IDI). Each MU’s average ﬁring rate was calculated as
the inverse of its mean IDI.
6.1.5 Statistics
Mean ± standard deviation was used as the measure of central tendency for
all descriptive statistics. One‐way ANOVAs with post hoc Tukey’s Honestly
Significant differences test were used to compare parametric data across disease
severity groups. Differences in non‐parametric data were assessed with Kruskal‐
Wallis and Dunn’s multiple comparisons post hoc test. A two‐way ANOVA with a
post‐hoc Bonferonni correction was used to compare torque across disease severity
(main effect 1) and frequencies (main effect 2). A one‐way ANOVA with post hoc
Tukey’s honestly significant differences test was used to compare MUP properties
between OA and control subjects and between contractile intensities. Level of
significance was set at p<0.05. All statistical tests were performed with Graphpad
Prism Version 5.0b (La Jolla, CA).
6.2 RESULTS
6.2.1 Evoked contractile properties of the quadriceps
Total WOMAC score was significantly different between all groups with post‐
hoc testing (p<0.05, Table 6.1). There was a significant difference for isometric knee
extensor torque across groups (p<0.05, Table 6.1). Post hoc testing revealed a
significant difference in normalized knee extensor torque between mild and severe
OA, with those in the severe group producing ~38% less torque. A significant
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difference was observed between moderate and severe groups with regard to height
and weight with post hoc testing (p<0.05), however, due to the lack of statistical
difference in strength between these groups, height and weight were not controlled
for with covariate analysis. The normalized torque‐frequency curves for mild,
moderate and severe knee OA are shown in Figure 6.1. Significant main effects were
observed for both frequency and disease severity (p<0.05). No interaction effect was
observed (p = 0.99). Post hoc Bonferroni correction did not reveal any significant
differences between disease severity groups at any of the 14 frequencies tested.
Similarly, no differences in evoked resting twitch properties were observed between
groups for PT, TPT or HRT (p>0.05, Table 6.2), although the between‐group
differences for PT did approach significance (p=0.06).
6.2.2 Needle and surface detected quadriceps motor unit potentials
Disease severity measured by WOMAC score was significantly lower in the
control versus OA group (p<0.05, Table 6.3). No significant differences were
observed for age, height, weight, BMI or normalized knee extensor torque (p>0.05,
Table 6.3). Due to the finding that no differences in normalized strength existed
between groups, a second analysis on strength was performed comparing the mild
OA participants from the contractile properties study and the healthy controls from
the MU properties study. No significant difference was observed between these
groups (p<0.05). Size‐related parameters of the N‐MUPs and S‐MUPs, as well as
mean MU firing rates were determined (Table 6.4). The final analysis was
conducted on 27±2 (control 10% MVC), 28±5 (control 20% MVC), 24±3 (OA 10%
MVC) and 25±6 (OA‐20% MVC) N‐MUPs per participant. No significant differences
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Table 6.1 Participant characteristics by disease severity subgroup.
Mild
Moderate Severe
pvalue
Sex (male/female)
8/5
8/5
5/8
Age
0.41
60.8±8.1 58.5±5.5
61.6±4.4
Height (m)
1.68±0.10 1.75±0.10 1.66±0.05* <0.05
Weight (kg)
79.7±9.8* 101.2±16.1 85.0±16.0* <0.05
BMI (kg/m2)
0.057
28.2±3.9 33.2±5.5
30.8±5.6
Total WOMAC score
19.4±8.4 40.9±6.0†
60.3±7.2*† <0.05
Knee Extensor MVC (N•m/kg) 2.17±0.84 1.97±0.76 1.35±0.55† <0.05
Data are presented as means±standard deviations. BMI: Body mass index; WOMAC:
Western Ontario and McMaster Osteoarthritis Index; MVC: maximal voluntary
contraction.
*Significantly different than moderate OA (p<0.05)
†Significantly different than mild OA (p<0.05)
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Table 6.2 Resting evoked twitch properties of the quadriceps by disease severity
group.
Mild
Moderate Severe
pvalue
PT (N•m) 26.9±7.3 29.6±9.7
22.4±4.7 0.06
TPT (ms) 112±11 111±18
0.85
114±7
HRT (ms) 100±35 84±37
111±43 0.22
Data are presented as means±standard deviations. PT: Peak twitch tension; TPT:
Time to peak twitch tension; HRT: Half‐relaxation time.
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Table 6.3 Participant characteristics for OA and control groups.
Control
OA
Male/Female
4/4
4/4
Age
61.8±5.9 61.3±3.8
Height (m)
1.69±0.07 1.72±0.09
Weight (kg)
77.9±24.0 99.9±20.3
BMI (kg/m2)
27.0±27.3 33.4±4.6
WOMAC Score
0.75±0.76 42.4±14.8
Knee Extensor MVC (N•m/kg) 1.87±0.49 1.47±0.43
Data are presented as means±standard deviations.
*Significant difference between groups (p<0.05)

136

pvalue
0.84
0.46
0.069
0.054
<0.05*
0.11

Table 6.4 Needle and surface motor unit potential parameters at two different
contraction intensities for OA and control participants.
10% MVC
Control
OA

20% MVC
Control
OA

NMUP Parameters
Peak‐to‐peak voltage (μV) 505±318
505±318
437±216
548±295
Duration (ms)
12.1±4.9
12.2±4.9
12.0±4.9*
10.5±5.1
AAR
1.7±0.5
1.9±0.6*
1.7±0.5
1.9±0.5*
SMUP Parameters
Negative peak amplitude
32±24.0
35.0±51.8
41.2±29.2
41.7±29.2
(μV)
Negative peak duration
9.6±2.4
9.7±3.9
8.9±2.6
9.0±2.4
(ms)
Negative peak area
142.8±101.5 152.4±172.9 180.4±122.4 173.2±98.7
(μV•ms)
Firing rate (Hz)
8.6±1.8
8.0±1.7*
9.1±1.9
8.4±1.8*
Data are presented as means±standard deviations. N‐MUP: needle motor unit
potential; AAR: area‐to‐amplitude ratio, S‐MUP: surface motor unit action potential.
*Significant difference between Control and OA groups (p<0.05).
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Figure 6.1 Torque‐frequency curves for mild (open circle), moderate (solid square)
and severe (open triangle) for 500 ms pulse trains of differing frequency. No
significant difference was observed across disease severity group for any frequency
of stimulation (p>0.05).
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between groups in the number of N‐MUPs per participant were noted, thus no single
subject was more representative of group statistics than any other (p>0.05). Mean
N‐MUP peak‐to‐peak voltage was not significantly different between groups at
either contraction intensity (p>0.05, Table 6.4). A significant increase in N‐MUP
duration was observed in the OA group at 20% MVC, but not at 10% MVC (p<0.05,
Table 6.4). The area‐to‐amplitude ratio (ARR), also known as N‐MUP “thickness”
was significantly greater in OA versus control subjects at both contraction
intensities (p<0.05, Table 6.4). N‐MUP complexity as measured by the number of
turns (10% MVC: OA=3.2±1.3, control=3.5±1.8; 20% MVC: OA=3.0±1.1,
control=2.9±1.2) and phases (10% MVC: OA=2.7±0.9, control=2.9±0.9; 20% MVC:
OA=2.6±0.7, control=2.6±0.7) was not significantly different between groups
(p>0.05). No differences were observed in S‐MUP size parameters (negative peak
amplitude, duration and area) between groups at either contraction intensity
(p>0.05, Table 6.4). Firing rates were slightly, but significantly lower in the OA
group at both contraction intensities (p<0.05, Table 6.4).
6.3 DISCUSSION
We observed that quadriceps muscle contractile properties remain unaltered
across a clinical spectrum of knee OA, despite lower quadriceps muscle strength in
those with severe knee OA. As quadriceps contractile properties provide
information about the relative proportion of type I and type II muscle fibres within a
given muscle, this observation indicates that muscle fibre composition is similar
between disease severity subgroups. Experimental models of chronic disuse have
observed speeding of muscle contractile properties reflecting a switch to the
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expression of faster type II muscle fibres.12 Thus, muscle weakness in severe knee
OA is likely not accompanied by large changes in muscle fibre phenotype.
Interestingly, even in the absence of muscle weakness, MU behaviour and possibly
morphology was altered at low contraction intensities in those with knee OA
compared to healthy controls in the second part of this study. Although preliminary,
these results suggest that if progressive changes are occurring to the neuromuscular
system in knee OA, they are subtle. It remains to be determined whether these
changes are due to permanent MU remodeling or reflect a compensatory
recruitment strategy in response to OA symptoms or structural changes.
6.3.1 Reduced isometric quadriceps strength across a clinical spectrum of
knee OA
Quadriceps muscle weakness in patients with knee OA compared to healthy
controls or a healthy contralateral limb, have been documented for both isometric
and isokinetic muscle contractions 6. However, in these studies, radiographic
criteria such as KLG are commonly used to define knee OA. Furthermore, OA is
usually defined dichotomously as present or absent, which does not provide
information about OA severity. Palmieri‐Smith et al. stratified OA patients using
KLG and reported no difference in strength between those with moderate versus
severe radiographic OA. Conversely, we observed that isometric knee extensor
strength normalized to body mass was ~38% lower in severe versus mild clinical
knee OA. Using a clinically relevant predictor variable may be more appropriate
when measuring clinically relevant outcomes, in particular quadriceps muscle
strength. Quadriceps muscle weakness is associated with pain and disability,2, 22, 23
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while the relationship between radiographic disease and strength is weak or non‐
existent.2, 3, 27 Furthermore, the tenuous relationship noted between clinical and
radiographic features of knee OA adds to the complexity of using predictor variables
that are not clinically‐oriented.4
It is surprising then that no difference in normalized strength between
healthy controls and OA subjects was observed in the study of MU properties (Table
6.3). As the goal of this experiment was obtain information about MU properties,
only a small number of participants were recruited due to the ability to sample large
numbers of MUs within each participant. It is possible that low sample size led to
type II error in this portion of the study as there was a non‐significant ~22%
difference between groups. Alternatively, unlike the first part of the study, the
participants in the OA group were not stratified for clinical disease severity and
some of the participants had WOMAC scores consistent with those in the mild and
moderate groups may have caused increased variability in strength in the OA group.
6.3.2 Evoked contractile properties across a clinical spectrum
Quadriceps muscle weakness has traditionally been attributed to disuse
atrophy in a painful knee joint.6 Chronic disuse atrophy, such as disuse associated
with muscle paralysis following spinal cord injury is associated with a rightward
shift in the torque‐frequency relationship and a speeding of TPT and HRT, which are
all indicative of a relative increase in the proportion of type II, fast twitch muscle
fibres.26 To our knowledge, this is the first study to examine evoked contractile
properties in patients with knee OA. The results of our study do not substantiate
knee OA as a model of chronic disuse as we observed no differences in the
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quadriceps torque‐frequency relationship or twitch properties across a clinical
spectrum of knee OA. It is possible that the effects of disuse associated with knee
OA are not so severe as to initiate alterations in fibre type, but do cause reductions
in muscle fibre size. Peterson et al. reported small but significant differences
(~12%) in mid‐thigh quadriceps cross‐sectional area between an ipsilateral limb
with severe radiographic knee OA and a contralateral healthy limb.24 In our study,
PT was ~17‐25% lower in the severe compared to the mild and moderate OA
groups, a result that approached, but did not reach statistical significance (p = 0.06).
Reduced PT without concomitant changes in speed‐related twitch properties and the
torque‐frequency relationship would indicate that only muscle fibre size is affected
in knee OA. In models of disuse where EMG activity is minimized (e.g.
immobilization) atrophic changes are much more pronounced than in disuse models
where only weight bearing is minimized (e.g. space flight, bedrest).12 Additionally,
the effect of disuse on muscle fibre phenotype is time dependent, such that longer
studies allowing for less electromyographic activity may have a greater effect on
MHC gene expression.12 While activity levels were not controlled in this study, all
participants were mobile and community dwelling and thus their activity levels
were much higher than those in experimental disuse studies. Also, we did not
control for duration of symptoms in this study. Mannion et al. reported that
duration of symptoms in patients with chronic back pain predicted the greatest
proportion in variance of fast‐fatigable type IIX fibres in the paraspinal muscles.21 It
is possible that duration of symptoms rather than symptom severity would exert a
greater influence on MHC expression. Due to the lack of stimulation frequency
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related contractile changes and the relatively high activity levels of the participants
in the study, we speculate that the reduction in muscle strength observed across a
clinical spectrum of muscle weakness was predominantly due to reduced muscle
fibre size.
6.3.3 Differences in needle and surface motor unit parameters between OA
and control participants
DQEMG is a fast, valid and reliable method of deriving quantitative
information from needle and surface EMG signals.8, 10 MUPs, in turn provide
information about MU morphology and physiology that is sensitive to pathological
processes affecting the motor unit.30 In particular, both N‐MUPs and S‐MUPs can
provide complementary information about MU size. In this study, there was no
difference in N‐MUP peak‐to‐peak voltage between OA and control groups. It is well
known that N‐MUP amplitude represents the contribution of only those muscle
fibres activated within close proximity of the recording electrode and is affected by
principles such as temporal dispersion and variation in terminal axon conduction
velocity.30 Other N‐MUP parameters such as duration and AAR, or “thickness” are
not as affected by electrode position and likely provide supplementary information
about MU size.30 Increases in duration and thickness suggest that more muscle
fibres are contributing to the resultant MUP. We observed that thickness (at both
contraction intensities) and duration (at 20% MVC only) were significantly larger in
the OA group. These observations are usually interpreted as evidence that collateral
reinnervation has taken place whereby denervation leads to collateral sprouting and
a subsequent increase in the number of muscle fibres per MU.30

144

Interestingly, S‐MUP amplitudes were not significantly different between
groups. S‐MUP amplitude is thought to be the parameter that best represents MU
size, since the surface electrode detection area is much larger, thereby
encompassing a greater proportion of muscle fibres for a given MU.11, 29 No
between‐group difference in S‐MUP negative peak amplitude could indicate
similarly sized MUs, however there was large variability in S‐MUP negative peak
amplitude between groups (Table 6.4). Electrophysiological studies from studies of
healthy older adults suggest that MU remodeling is a chronic process, often
requiring decades to manifest 6. In this regard, it is possible that MU remodeling is
occurring in OA patients, but the process is not chronic enough to induce
widespread alterations in MU size. In support of this hypothesis, we present the
frequency distributions of S‐MUP amplitudes at both contraction intensities for OA
and control participants for the present study as shown in Figure 6.2. In a previous
study we speculated that a qualitative rightward shift in the frequency distribution
of S‐MUP amplitudes indicates that only select MUs had increased in size through
collateral reinnervation.11 Particularly at the 20% contractile intensity, the OA
participants had greater numbers of larger amplitude S‐MUPs. In keeping with the
evidence for mild‐to‐moderate as opposed to chronic disuse atrophy described
above, it is possible that only early MU remodeling is apparent in the vastus medialis
in knee OA.
6.3.4. Reduced motor unit firing rates in OA participants
This is the first study to report reduced MU firing rates at submaximal
contraction intensities in the vastus medialis muscles of patients with knee OA.
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Figure 6.2 Distribution of S‐MUP amplitudes expressed as total number per bin at
the 10% (upper panel) and 20% (lower panel) contractile intensities for control
(open bars) and OA (solid bars) participants. Particularly at the 20% intensity, it
appears that the OA participants had a greater number of relatively large S‐MUPs,
signifying a tendency towards increased motor unit size. S‐MUP: surface motor unit
action potential.
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Reduced MU firing rates may be a compensatory response to increased MU size. It
has been proposed that increases in MU size due to accumulation of increased
number of muscle fibres results in increased torque output per MU.25 As a result, the
discharge rate required to maintain a given torque output is less than for a smaller
MU. Thus small reductions in MU firing rate could be complementary to the small
increases in MU size observed in this study. Alternatively, it has been shown in
experimental pain models that MU firing rate and MU recruitment strategy are
altered. Tucker et al. injected the infrapatellar fat pad with hypertonic saline to
induce pain and reported reduced MU firing rates and a greater contribution from
more MUs to maintain submaximal force.32 In our study, OA participants had
significant knee pain compared to healthy controls. It is unknown whether
increases in recruitment were responsible for maintenance of torque output to
compensate for reductions in firing rate.
The significance of such small reductions in MU firing rate between OA and
control participants (< 1Hz) is questionable, however larger muscles such as the
vastus medialis have been shown to grade force through recruitment as opposed to
rate coding strategies, such that step increases in contractile intensity are
accomplished predominantly through increases in recruitment.25 Accordingly, MUs
in this muscle have been shown to have a narrow range of firing rates
(approximately 8‐26 Hz).25 In such a narrow window, it’s possible that even small
changes in firing rates may indicate significant changes in motor control.
6.3.5. Limitations
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There are a few caveats to interpretation of the data. First, testing of evoked
contractile properties may be an insensitive method for measuring change at the
muscle fibre level. Roos et al. measured contractile properties of the quadriceps in
young and old participants and found only very modest changes in speed related
contractile properties, despite large differences in isometric muscle strength and a
~55 year age difference between groups.25 It is possible that changes could be
occurring at the muscle fibre level, but do not manifest at the whole muscle level.
Fink et al. performed histochemical analysis on muscle fibres biopsied from the
vastus medialis in knee OA patients at the time of surgery and reported selective
type II fibre atrophy in 68% patients and type I (15% of patients) and type II (37%
of patients) fibre type grouping, as evidence of a collateral reinnervation process.15
Selective type II fibre atrophy is more indicative of age‐associated changes (i.e.
sarcopenia)13 although it could be that type II fibres appear more affected in the
quadriceps due its relative large complement of Type II muscle fibres.19 Further
investigation is necessary to determine if fibre types are different in the quadriceps
of knee OA patients.
Second, we did not obtain information about MU recruited at higher
contraction intensities. Pilot testing revealed that many participants could not
maintain a contraction intensity ≥ 30% MVC for 30 s. However, due to the proposed
reliance of the vastus medialis on recruitment to grade force,25 it could be argued
that a step transition in contractile intensity from 10% to 20% MVC provided
meaningful information about different MUs at each contraction intensity.
Unfortunately, it is difficult both technically and physically (i.e. from the perspective
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of the patient) to contract and sample MUs at higher contractile intensities in this
muscle.
The results of this study serve to further understanding of the mechanisms of
quadriceps muscle weakness in knee OA. Our observation of increases in N‐MUP
size parameters and reductions in firing rates, suggest that deficits in muscle
strength in knee OA are accompanied by early pathological changes at the level of
the MU. However, these changes were not accompanied by a difference in whole
muscle evoked contractile properties indicating that even in severe OA, chronic
disuse alterations have not taken place (e.g. speeding of muscle fibre contractile
properties due to increased proportion of fast twitch, type II muscle fibres). Overall,
our results support a model of early disuse. The clinical significance of these
findings is unclear, but pathological changes to the MU may impact on function and
disease prognosis.
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CHAPTER 7
GENERAL DISCUSSION AND SUMMARY

7.0 GENERAL DISCUSSION
The results of this thesis have implications for: 1) defining disease severity
and measuring clinically related outcomes in knee OA, 2) understanding the
mechanisms of muscle weakness and 3) improving rehabilitation of neuromuscular
dysfunction in knee OA. In Chapter 2, it was observed that defining knee OA using
radiographic criteria in isolation may lead to inaccurate outcome measurement,
particular if the outcome of interest is a clinically relevant measure (e.g. quadriceps
muscle strength). The results from Chapter 4 suggest the measurement of whole
muscle volume derived from high contrast and resolution MRI is a valid outcome
measure as it predicted a significant proportion of the variance in muscle strength.
In this study we also established the reliability of different manual segmentation
methods for the first time.
The observations in chapter 2 provided justification for the use of WOMAC
(i.e. clinical disease severity) as the independent variable in Chapters 3, 5 and 6.
Participants were stratified into tertiles of disease severity according to raw
WOMAC scores. In Chapter 3, it was observed that not only is strength reduced
across a clinical spectrum of knee OA, but also muscle isotonic power (the product
of knee extensor torque and velocity of contraction). Furthermore, the deficits in
muscle power, particular at lower contraction intensities were larger than those
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observed for strength and predicted a larger proportion of the variance in self‐
reported function. The implication of this finding is that reducing deficits in
quadriceps velocity and power may better attenuate the decline in function seen in
this patient population.
Chapter 3, 4, 5 and 6 provided information about the mechanism of
quadriceps neuromuscular dysfunction in those with knee OA. Traditionally,
quadriceps muscle weakness has been attributed to disuse atrophy as a result of
knee pain.2 The results of our study lend support to the disuse model but show
some deviation from experimental studies of disuse. The reductions in strength and
power in those with severe knee OA were not accompanied by changes in specific
torque or power (i.e. muscle quality). It can be inferred from this result that
quadriceps muscle deficits are due predominantly to reduced muscle fibre size. This
finding was supported in Chapter 3 and 5 where muscle mass was shown to be the
greatest predictor of the variance in isometric strength (Chapter 3) and VA deficits
were small and even those with severe knee OA achieved VA = 90% (Chapter 5).
The finding that of high levels of VA in OA patients is contrary to the findings of
similar studies7, 9, 12 and is not consistent with experimental models of
immobilization.3 However, knee OA is not an experimental model of disuse and we
did not control for patient activity levels in this study (see section 7.1), therefore it’s
possible that the effects of disuse in this population are restricted to the muscle fibre
size, such that type II fibres are selectively affected by disuse. In Chapter 3 we
observed that deficits in power were significant only at the higher contractile
intensities and velocity was similarly affected at only the highest velocities. As type
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II, fast twitch muscle fibres are recruited only during high intensity, high velocity
contractions, the deficits observed are consistent with a selective type II fibre
atrophy model. Subsequently in Chapter 6, we did not observe alterations in evoked
contractile properties to suggest any long‐term alterations in muscle fibre
phenotype.
One of the most novel findings in this study was increased MU size and
slightly reduced MU firing rates in those with severe knee OA compared to healthy
controls. As the contractions used in this study were of relatively low intensity
(10% and 20% MVC) it is likely that we undersampled larger, faster MUs to get a
representative sample. However, the vastus medialis is known to be a muscle that
grades torque predominantly through MU recruitment (as opposed to rate coding)
and thus we likely sampled a different population of MUs at each contraction
intensity. The significance of the MU remodeling and reductions in firing rate is
unclear and could represent either a pathological or compensatory process.
7.1 LIMITATIONS
There were several limitations to the interpretation of the results of these
studies:
1) A central limitation mentioned in Chapters 2, 3, and 5 was the use of an ordinal
measure (i.e. WOMAC) as a disease stratification tool. As there are currently no
universally accepted criteria to define disease severity in knee OA,6 there is
significant variation in disease definition between studies. A simple method for
defining mild, moderate and severe knee OA is using KLG, where KLG<2 is mild, KLG
= 2 is moderate and KLG>2 is severe.13 However, we observed a discrepancy in
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outcome measurement when using clinical versus radiographic disease definitions,
which provided the justification for using WOMAC as a predictor variable. Although
WOMAC has been well validated, it is usually used as an outcome measure and is a
subjective, ordinal measure with inherent limitations. In spite of using WOMAC to
create clinically homogeneous subgroups, some patients with scores near a cutoff
were likely dissimilar clinically from those with less extreme scores. It is unknown
if our groups would have been more homogenous had we employed a disease
definition encompassing both clinical and radiographic criteria, however we were
not able to obtain X‐rays for all study participants.
2) As participants were community dwelling and recruited from outpatient clinics,
control over some participant characteristics was not feasible. Accordingly we
could not control for factors that may have influenced the study results. For
example, some participants in all groups had previously undergone injection
therapy for knee pain. Galban et al. reported that knee joint intrusion with saline
alters quadriceps muscle metabolism with accelerated depletion of energy stores
and fatigue during stimulation in rats.5 It’s possible that cortisone or hyaluronan
injections alter muscle outcomes independent of the effects of disease severity.
Other potential study confounders that were not subject to control included physical
activity levels, medications, compartmental distribution of knee OA, degree of knee
laxity, degree of antagonist co‐contraction and etiology of OA (i.e. primary versus
secondary/traumatic). In spite of the influence of potential confounders on our
results, the findings of this study do have external validity and extend to community
dwelling men and women.
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3) The measure of disability used in these studies (i.e. WOMAC function subscale)
was self‐reported and therefore subjective. The literature supporting the notion
that deficits in muscle power are stronger predictors of disability than strength are
based on objective performance measures.1, 10 It is unclear if the associations
observed between strength, power and disability would have persisted or been
stronger if more objectives measures were used (Chapter 3). Similarly, the degree of
VA was not associated with self‐reported function (Chapter 5) and it is unclear if VA
deficits have any impact on functional performance.
4) As mentioned above, the MUs analyzed in Chapter 6 were only sampled during
low intensity contractions. Participants were either unable to sustain an isometric
knee extension contraction at higher contractile intensities, or the interference
pattern generated at higher intensities was too complex to decompose in a
reasonable period of time for the participants. Thus, it is unknown if remodeling
(i.e. increases in size) and reduced firing rates would also be evident in MUs
recruited at higher contractile intensities.
5) There are limitations inherent in the cross‐sectional design employed herein.
Primarily, temporality of associations cannot be established. For example in
Chapter 4, participants in the severe group had reduced muscle volume compared to
those with mild OA. However, it is unclear whether reduced muscle mass precedes
or follows changes in clinical disease severity and thus inferences made about the
natural history of quadriceps muscle weakness in knee OA are speculative.
7.2 FUTURE DIRECTIONS
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There is still much to understand about quadriceps neuromuscular function
in knee OA. First, further information about the natural history of quadriceps muscle
function, particularly with respect to changes in muscle volume and intrinsic muscle
properties is required. This can be accomplished by assessing patients
longitudinally, however such a study would be difficult as the clinical course of knee
OA from first visit to primary care, through to joint replacement can be quite
variable. Additionally, as mentioned above, our results would be supported by
studies employing more objective measures of functional performance. Another
feature of study design that would build on these findings would be to correlate our
data on MU properties with information about muscle fibre histology. Fink et al
showed changes consistent with selective type II fibre atrophy in patients with knee
OA at the time of arthroplasty4 and it would be interesting to determine whether
these changes are accompanied by alterations to the MU.
As mentioned throughout, our findings having implications for rehabilitation
and prognosis, although these results are preliminary in that they provide only the
foundation for further testing. Treatment of knee OA targets symptoms only and is
not currently disease modifying.8 Furthermore, muscle function preceding
arthroplasty predicts success on functional performance tests post‐arthroplasty.11
Muscle deficits have also been observed post‐arthroplasty12 and it is unknown if
muscle power and intrinsic muscle fibre and motor unit properties are affected after
knee arthroplasty. Studies are required to determine 1) the effect of current and
new interventions on MRI‐derived measures of muscle mass, 2) the efficacy of
treatments that specifically affect deficits in muscle power on strength and quality of
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life measures, 3) the impact of strength, power and intrinsic muscle deficits post‐
knee arthroplasty and 4) whether quadriceps neuromuscular deficits persist post‐
arthroplasty.
7.3 SUMMARY
Quadriceps neuromuscular dysfunction in those with severe knee OA
encompasses much more than reductions in isometric muscle strength. The results
of this thesis revealed deficits in muscle volume, isotonic power and alterations to
MUs in those with severe compared to mild knee OA or healthy control. Our results
also suggest that knee OA is accompanied by reductions in muscle fibre size
(particularly of the type II fibres), although this result needs to be substantiated.
Perhaps most importantly, the results of this study likely have direct implications
for patient care. As clinical findings are often discrepant from radiographic findings,
the use of X‐rays to make treatment and referral decisions may not result in
appropriate patient care. Furthermore, targeting the mechanisms of muscle
weakness with specific interventions (e.g. deficits in power) may result in greater
attenuation of disability experienced by this disease population.
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APPENDIX D

Output screen for decomposition of the needle EMG interference pattern during a 30
s contraction of the vastus medialis in a healthy control subject. Five individual
motor unit potential trains were identified (labeled 1‐5 on the far left). Panel
descriptions from left‐to‐right: MUP Template: individual needle motor unit
potential trains representing the median of 51 N‐MUPs assigned to the template;
MUP Stability: Shimmer plot of the 51 N‐MUPs; SMUP Template: SMUP derived from
spike‐triggered averaging of the needle signal; IDI Histogram: Distribution of the
IDIs for the N‐MUPs comprising the motor unit potential train; Firing Graph: plot of
the firing rate characteristics (inverse of the IDI) over the 30 s interval. EMG:
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electromyography; N‐MUP: needle motor unit potential; SMUP: surface motor unit
potential; IDI: interdischarge interval.
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